case_id,mode,case_type,iteration,Q0_answer,Q0_reasoning,Q1_answer,Q1_reasoning,Q2_answer,Q2_reasoning,Q3_answer,Q3_reasoning,Q4_answer,Q4_reasoning,Q5_answer,Q5_reasoning,Q6_answer,Q6_reasoning,Q7_answer,Q7_reasoning,Q8_answer,Q8_reasoning,input_tokens,output_tokens,total_tokens
Case3223,rag,all_correct,iter2,BRCA1/2,Patient was referred for BRCA1 and BRCA2 testing (clinical information states BRCA1 and BRCA2 testing was requested).,Not Specified,The policy contains age-based criteria for cancer-affected cases but does not impose an upper age limit or specific age restriction for testing of unaffected individuals; no age restriction applicable to this unaffected 75-year-old is specified in the policy.,No,"Policy requires testing be performed in a setting with suitably trained providers who can give appropriate pre- and post-test counseling. The referral is from a general practitioner and there is no documentation of pre-test genetic counseling, so ordering/provider requirements are not met per the provided information.",Yes,"Policy states testing for unaffected individuals is medically necessary if they have a 1st- or 2nd-degree blood relative who meets the criteria for Patients With Cancer. The patient has a sister (1st-degree) with epithelial ovarian carcinoma, which meets the policy's cancer-family-history criterion.",Not Specified,"Policy strongly recommends testing an affected family member first when possible, but it does not state a firm required prior test that must be completed before testing an unaffected relative; no specific mandatory prior test is defined in the policy for this scenario.",Yes,"Policy criteria explicitly consider family history; patient has a relevant family history (sister with epithelial ovarian cancer), which is a first-degree relative meeting policy criteria.",No,"Policy requires appropriate pre- and post-test genetic counseling by suitably trained providers. The clinical information states there is no documentation of pre-test genetic counseling, so counseling requirements are not satisfied.",Not Specified,The provided policy document does not map BRCA1/2 testing to any specific CPT code; no CPT coding guidance is specified in the policy text supplied.,No,"Although the patient meets the clinical/family-history medical-necessity criteria for BRCA1/2 testing, the policy requires testing be performed in a setting with suitably trained providers who can provide appropriate pre- and post-test genetic counseling. There is no documentation that pre-test genetic counseling has been provided, so coverage requirements per the policy are not met based on the provided information.",18927,2274,21201
Case14226,rag,all_correct,iter2,BRCA1/2,Patient is being evaluated by oncology for germline BRCA1 and BRCA2 testing; policy MOL.TS.238.A addresses BRCA analysis (BRCA1/2).,Yes,"Policy age requirement for BRCA testing (Known familial, Ashkenazi founder, and Full Sequence Analysis) specifies age 18 years or older; patient is 55, meeting the >=18 requirement (MOL.TS.238.A).",No,"Policy requires pre- and post-test genetic counseling by an appropriate provider for BRCA testing. Patient information states no pre-test genetic counseling was completed, so ordering-provider/counseling requirements are not satisfied per the policy.",No,"Policy defines specific diagnostic and personal/family-history criteria for BRCA full sequence analysis (e.g., breast/ovarian/pancreatic/prostate cancer, age-specific breast cancer criteria, specific family history). Patient has a non-specific 'primary solid tumor' and a maternal hematologic/immunologic disorder that do not meet the policy's listed BRCA clinical indications.",Yes,"Policy requires no previous full sequencing/known BRCA mutation for full sequence analysis. Patient has not undergone prior genetic testing, satisfying the 'no previous genetic testing' requirement in the guideline.",No,The policy specifies family-history criteria (breast/ovarian/pancreatic/prostate cancers in defined relatives). The patient's family history (mother with hematologic/immunologic disorder) does not meet those specified cancer-related family-history criteria.,No,"Policy explicitly requires pre- and post-test genetic counseling by an appropriate provider for BRCA testing. Patient documentation states no pre-test genetic counseling was completed, so counseling requirements are not met.",81162,Policy procedure table lists CPT 81162 for BRCA1/2 full sequencing and duplication/deletion analysis (appropriate when sequencing and deletion/duplication analysis are performed concurrently).,No,"Although age and absence of prior testing meet policy requirements, the patient does not meet the policy-defined clinical indication/family-history criteria for BRCA testing and has not completed the required pre-test genetic counseling; per MOL.TS.238.A, these unmet criteria support denial of coverage.",10313,1836,12149
Case10451,rag,all_correct,iter2,WES,Patient was referred by neurology for whole exome sequencing (WES) to evaluate an unexplained neurodevelopmental disorder (patient info).,Yes,"Policy eligibility for WES includes 'Moderate, severe, or profound Intellectual Disability diagnosed by 18 years of age.' The patient is 10 years old with moderate–severe ID diagnosed in childhood, meeting the age-based criterion (policy Coverage Rationale).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is a neurologist (patient info), meeting policy requirement.",Yes,"Policy medical indication requires nonspecific clinical presentation and one qualifying feature (e.g., moderate–severe intellectual disability diagnosed by 18). Patient has unexplained neurodevelopmental disorder with moderate–severe ID diagnosed in childhood and nondiagnostic prior CMA, satisfying the clinical indication (policy Coverage Rationale).",Not Specified,"The policy does not mandate prior testing (CMA) before WES generally; it only advises targeted testing if a specific syndrome is suspected. Patient had prior CMA nondiagnostic, but policy does not specify mandatory prior tests for WES (policy Coverage Rationale).",No,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' or consanguinity as supporting criteria. The sibling history describes a brief resolved unexplained event (altered responsiveness), not clearly 'similar clinical features' to the proband's ID, so relevant family-history criteria are not met (policy Coverage Rationale / Definitions).",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not state it as a hard coverage prerequisite. There is no documentation of counseling (patient info), but counseling is recommended, not required per policy (policy Description of Services).",81415,"Policy lists CPT 81415 for 'Exome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' which corresponds to WES (policy Applicable Codes).",Yes,"Under the policy WES is proven and medically necessary when all criteria are met: nonspecific/unexplained presentation, ordering provider specialty (neurologist), and a qualifying feature such as moderate–severe intellectual disability diagnosed by 18. The patient is a 10‑year‑old with moderate–severe ID, an unexplained neurodevelopmental disorder, neurologist ordered WES, and prior CMA was nondiagnostic — therefore coverage criteria are met (policy Coverage Rationale; patient info).",36961,1854,38815
Case4196,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) is being requested as the next diagnostic step.,Not Specified,The policy refers to 'children' and pediatric indications but does not state a specific age cutoff; no explicit age-based eligibility criteria are provided in the policy.,Not Answerable,"Policy requires documentation that the individual 'has been evaluated by a clinician with expertise in clinical genetics'; the patient record notes referral by a cardiologist and that pre-test genetic counseling was completed, but it does not explicitly document evaluation by a clinician with expertise in clinical genetics or identify the ordering provider's specialty.",Yes,Policy: WES may be medically necessary for children with unexplained neurodevelopmental disorders when criteria met. Patient: 10-year-old with unexplained developmental delay/intellectual disability (neurodevelopmental disorder) for evaluation—meets the defined clinical indication.,Yes,"Policy criterion allows WES when 'previous genetic testing has failed to yield a diagnosis.' Patient had prior FISH testing that was nondiagnostic, satisfying the 'previous testing failed to yield a diagnosis' condition.",Yes,"Policy lists family history of developmental delay as relevant. Patient has a brother diagnosed with moderate to severe intellectual disability in childhood, which is a relevant family history per policy.",Yes,"Policy requires counseling as part of criterion 1. Patient information documents that pre-test genetic counseling has been completed with plans for post-test follow-up, meeting the counseling requirement.",Not Specified,The provided BCBS FEP policy text does not list or reference CPT codes for WES; no CPT mapping is specified in the document.,Yes,"Based on the policy, WES may be considered medically necessary for children with unexplained neurodevelopmental disorders when all criteria are met. The patient is a child with unexplained developmental delay/ID, prior genetic testing (FISH) was nondiagnostic, pre-test genetic counseling was completed, and there is relevant family history—together meeting the policy's indications for medically necessary WES.",14850,2886,17736
Case18281,rag,all_correct,iter2,WGS,Patient clinical info states the cardiologist ordered whole genome sequencing (WGS).,Yes,"Policy age-related references use diagnoses by age ≤18 for qualifying features; patient is 6 years old, which meets the pediatric age context in the WGS criteria.",No,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a cardiologist, which does not meet the listed provider requirement.",Yes,Policy lists 'multiple congenital anomalies (must affect different organ systems)' as a qualifying clinical feature for WGS; patient has multiple congenital anomalies that do not fit a well-delineated syndrome.,Yes,"Policy WGS criterion specifies 'Neither CMA nor WES have been performed.' Patient has only prior Fragile X testing (nondiagnostic) and no CMA or WES, satisfying this requirement.",No,Policy specifies family-history criteria such as other first- or second-degree family members with similar clinical features or consanguinity. Patient has a sibling with an inborn error of metabolism but no information that the sibling has similar clinical features or consanguinity; therefore the policy-specified family-history criterion is not met.,Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling an explicit mandatory coverage requirement; patient had no pretest counseling, but the policy does not require it for coverage determinations.",81425,"Policy's applicable CPT codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to WGS.",No,"Although the patient meets clinical-feature and prior-test criteria (multiple congenital anomalies; no prior CMA/WES) and is an appropriate pediatric age, the policy requires WGS be ordered by specific provider types (medical geneticist, neonatologist, neurologist, or developmental pediatrician). The ordering provider is a cardiologist, so the WGS request does not meet all policy coverage requirements.",36944,2444,39388
Case17196,rag,all_correct,iter2,CMA,Patient info explicitly states a referral for chromosomal microarray (CMA) testing.,Not Specified,The FEP policy lists clinical indications but does not impose age-based eligibility limits for CMA (postnatal use is specified but no age cutoff).,Not Specified,The policy discusses genetic counseling and clinical/genetics follow-up but does not specify required ordering-provider specialty or other ordering-provider constraints for CMA.,No,"The policy authorizes CMA as medically necessary for individuals with developmental delay/intellectual disability, autism spectrum disorder, or multiple congenital anomalies. The patient has adult neuropsychiatric diagnoses (bipolar/schizophrenia/OCD features) and does not meet those specified indications per the policy.",Not Specified,"The policy allows CMA as a first-line test in the stated indications and does not mandate completion of specific prior tests before CMA; although guidelines mention fragile X as part of first-tier for ASD, the policy does not require prior testing for CMA in general.",Not Specified,The policy's coverage criteria are phenotype-based (developmental delay/ASD/multiple congenital anomalies) and do not define family history or consanguinity criteria for CMA eligibility; the patient’s sibling history is noted but the policy does not make this a coverage criterion.,Not Specified,"The policy strongly recommends formal genetic counseling and states it should be performed by experienced personnel, but it does not state counseling is an explicit precondition for coverage of CMA; the patient has no pre-test counseling, but the policy does not make this an absolute eligibility requirement.",Not Specified,The provided FEP policy document does not list or map specific CPT codes to CMA testing; no CPT code is specified in the policy text.,No,"Per the FEP policy, CMA is covered only for developmental delay/intellectual disability, ASD, or multiple congenital anomalies. The patient's indication is adult neuropsychiatric illness (bipolar/schizophrenia/OCD features), which does not meet the policy's defined medically necessary indications; therefore the test is not covered.",15705,1809,17514
Case8288,rag,all_correct,iter2,WES,Patient info explicitly states whole exome sequencing (WES) is being pursued to evaluate the fetus.,Yes,"Policy includes specific prenatal WES criteria (applies to a fetus). The patient is a fetus at 36 weeks, so the age/gestational status fits the prenatal WES indication per the policy.",Not Answerable,"Policy requires prenatal WES to be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist; the clinical information does not state who specifically ordered the WES, so provider requirement cannot be confirmed.",Yes,"Prenatal WES criteria in the policy require (1) prior CMA/karyotype uninformative (met: CMA nondiagnostic) and (2) fetus with a congenital anomaly affecting a single organ system plus family history suggesting genetic etiology — patient has a major cardiac anomaly (single organ system) and family history of an inborn error of metabolism in an affected sibling, meeting the indicated clinical criteria.",Yes,"Policy requires CMA and/or karyotyping be performed and uninformative before prenatal WES; patient had a prior CMA that was nondiagnostic, satisfying the prior testing requirement.",Yes,"Policy lists relevant family history as an indication for prenatal WES. Patient has a family history of an inborn error of metabolism affecting an older sibling, which meets that family-history criterion.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make it an absolute coverage requirement. Patient info documents multiple genetic counseling sessions, but the policy does not mandate counseling as a strict required criterion for coverage.",81415,"Policy's applicable codes list CPT 81415 for exome (sequence analysis), which corresponds to WES.",No,"Although the clinical indications and prior testing (nondiagnostic CMA, fetal cardiac anomaly, relevant family history, and counseling) meet prenatal WES criteria in the policy, the policy also explicitly requires WES to be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist. The provided patient information does not document that the ordering provider meets that requirement, so not all policy coverage criteria are demonstrably met.",36980,2410,39390
Case3422,rag,all_correct,iter2,WES,Patient information explicitly states consideration of whole-exome sequencing (WES) after a nondiagnostic CMA.,No,"Policy Exome Sequencing criteria require the member to be <21 years of age; the patient is 34, so she does not meet the age-based eligibility criterion.",Not Specified,"The guideline requires appropriate genetic/family history evaluation and a clinical letter and recommends pretest counseling by a medical geneticist or affiliated genetic counselor, but it does not explicitly mandate a specific ordering provider specialty for ordering ES; patient was referred by oncology (no explicit conflict in the policy).",No,"The policy defines specific clinical indications (e.g., pediatric global developmental delay, multiple congenital anomalies, etc.). The patient has a single congenital choanal atresia without documentation of the policy-defined sets of congenital anomalies or neurodevelopmental criteria; therefore she does not meet the defined medical-indication criteria.",Yes,"Policy requires prior appropriate testing to be considered (and prenatal ES explicitly requires CMA/karyotype). The patient had a nondiagnostic chromosomal microarray (CMA) and has no prior ES/WGS per the provided facts, satisfying the stated prior-test requirements.",Not Specified,"The guideline requires a genetic and family history evaluation to be documented, but it does not define specific family-history or consanguinity thresholds for adult ES eligibility; the patient's maternal breast cancer history is noted but no policy-specified family-history criterion applies.",Not Answerable,"The policy requires pretest counseling (ACMG recommends counseling by a medical geneticist or affiliated genetic counselor) and a clinical letter with specific elements. The record states the patient 'has seen a genetic counselor multiple times' but does not confirm the presence of the required clinical letter or documented informed consent, so sufficiency cannot be determined from the provided information.",81415,Policy billing section specifies 81415 should be billed for proband exome sequencing (analyzing the entire exome).,No,"Although the patient had a nondiagnostic CMA and no prior ES/WGS, the policy requires the member to be <21 years of age as an absolute criterion for medical necessity; the patient is 34, therefore ES is not covered per the policy.",10464,2159,12623
Case5885,rag,all_correct,iter2,WGS,Patient information explicitly states 'whole genome sequencing (WGS) is requested.',Not Specified,"The policy contains no overall age cutoff for WGS; it includes some age-specific features (e.g., ID diagnosed by 18, seizure onset <3) but no general age-based exclusion — therefore no standalone age eligibility is specified for this request.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test was ordered by/through neurology, meeting the ordering-provider requirement.",No,"Policy requires WGS criteria include clinical presentation nonspecific AND one of listed features (e.g., multiple congenital anomalies, global developmental delay, moderate/severe ID by 18, epileptic encephalopathy <3) or two or more other listed features. The record documents a 'major abnormality affecting at least one organ system' only, with no documented qualifying features (e.g., multiple congenital anomalies, DD/ID, epilepsy, two or more listed features). Thus the patient does not meet the policy's defined medical indications for WGS.",Yes,"Policy states WGS is proven when 'Neither CMA nor WES have been performed.' The patient had Fragile X testing only (nondiagnostic) and no CMA or prior WES, satisfying the prior-test requirement for WGS.",No,"The policy lists relevant family-history criteria (e.g., other first- or second-degree family members with similar clinical features). The patient has maternal long QT syndrome, which is not documented as 'similar clinical features' to the proband's presentation, so the family-history criterion for eligibility is not met.",Yes,"The policy 'strongly recommends' genetic counseling prior to WGS/WES. The record documents that pre-test counseling was discussed with a genetic specialist and post-test follow-up is planned, meeting the counseling recommendation.",81425,"Policy applicable CPT mapping lists 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to WGS.",No,"Although ordering provider (neurologist), absence of prior WES/CMA, and documented genetic counseling meet policy elements, the patient does not meet the policy's required clinical-indication criteria for WGS (no documented qualifying features such as multiple congenital anomalies, global developmental delay, ID by 18, epileptic encephalopathy, or two or more listed features). Per the policy, WGS is covered only when those medical-necessity criteria are met; they are not met here.",36937,2808,39745
Case14195,rag,all_correct,iter2,BRCA1/2,Patient was referred specifically for BRCA1/2 testing (documented referral for BRCA1/2). Basis: patient clinical information.,Yes,Policy explicitly states testing of minors is investigational; the patient is 18 (an adult). Basis: policy statement that testing minors is investigational and patient age = 18.,No,"Policy requires testing be performed in a setting with suitably trained providers and appropriate pre-test counseling. Patient information states no pretest genetic counseling has been conducted, so ordering/provider requirements (counseling) are not satisfied. Basis: policy Genetic Counseling and Policy Statement requirements + patient facts.",No,Policy defines medical indications (personal cancer history meeting criteria or relevant family history of BRCA/PALB2-related cancers). Patient has no personal history of a BRCA-related cancer and family history reported (maternal uncle with dystonia/ataxia) is not a BRCA-related cancer; thus patient does not meet specified clinical criteria. Basis: policy indications for unaffected individuals and patient family history.,No,Policy strongly recommends testing an affected family member first when possible. No affected family member with relevant BRCA-related cancer has been reported or tested; prior karyotype was nondiagnostic and is not the recommended prior test. Basis: policy 'Testing Unaffected Individuals' guidance and patient facts.,No,"Policy specifies family history of BRCA-related cancers (breast, ovarian, pancreatic, prostate, etc.) as relevant. The reported family history (maternal uncle with dystonia and ataxia) is not a BRCA-related cancer; therefore relevant family history criteria are not met. Basis: policy family-history criteria and patient facts.",No,"Policy requires pre- and post-test genetic counseling by experienced providers. Patient information states no pretest genetic counseling was conducted, so counseling requirements are not met. Basis: policy Genetic Counseling section and patient facts.",Not Specified,The policy text does not provide or map specific CPT codes to BRCA1/2 tests. Basis: no CPT code guidance in provided policy document.,No,"Per policy, germline BRCA1/2 testing is medically necessary only when personal history or family history meets specified BRCA-related criteria or other policy conditions. This patient is an unaffected 18-year-old with no BRCA-related personal cancer history, no qualifying family history, no affected relative tested first, and no pretest counseling—therefore does not meet coverage criteria. Basis: policy 'Policy Statement' and 'Testing Unaffected Individuals' plus patient facts.",18924,2099,21023
Case2847,rag,all_correct,iter2,WES,Patient information states 'whole exome sequencing (WES) is being pursued.',Yes,Policy applies to children/infants for WES; the patient is a 5-week-old infant and the policy explicitly addresses infants (including BRUE) and children as eligible populations.,Yes,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled. The record documents pre-test counseling with a genetic counselor and family history/phenotype information, meeting the policy's clinician/counseling requirement.",Yes,"Policy guidelines list 'infant with high risk stratification on evaluation for a Brief Resolved Unexplained Event (BRUE) ... Required cardiopulmonary resuscitation (CPR)' as a clinical feature suggesting a genetic disease; patient had a high-risk BRUE requiring CPR and prior CMA was nondiagnostic, satisfying the policy's clinical indication.",Yes,"Policy criterion 3 requires prior genetic testing (eg, chromosomal microarray) to have failed to yield a diagnosis; patient had prior CMA testing that was nondiagnostic.",No,"Policy specifies relevant family-history items (eg, arrhythmia, BRUE in sibling, inborn error of metabolism, LQTS, early sudden unexplained death). The documented family history (mother with severe immunologic/hematologic disorder) is not among the policy's listed relevant family-history criteria.",Yes,"Policy states genetic counseling should be performed by an individual with experience in genetic medicine. The patient had pre-test counseling completed with a genetic counselor and plans for post-test follow-up, meeting the counseling requirement.",Not Specified,"The provided FEP policy text does not list or map specific CPT codes for WES, so no CPT code is specified in the policy document.",Yes,"Based on the policy, WES may be considered medically necessary for children when all criteria are met. The patient is an infant with a high-risk BRUE requiring CPR (listed as a clinical feature suggesting genetic disease), prior CMA was nondiagnostic, and genetic counseling was completed—therefore the policy supports coverage.",14852,2970,17822
Case11855,rag,all_correct,iter2,CMA,"Patient statement: ""chromosomal microarray (CMA) is being ordered to assess for copy number variants"" — the requested test is CMA per the clinical information.",Not Specified,The UHC CMA policy lists clinical indications but does not impose age-based eligibility limits for CMA; no age restriction is specified.,Not Specified,The policy strongly recommends pre-test genetic counseling and counseling by genetics experts but does not restrict ordering to a specific provider specialty or explicitly require a particular ordering provider type.,No,"Policy-defined covered indications include ASD, developmental delay/intellectual disability, multiple congenital anomalies, or isolated severe congenital heart disease. The patient has a single-organ congenital anomaly (organ not specified) and no documented DD/ID or ASD in the provided information, so the patient does not meet the policy's specific medical indications.",Yes,"The policy/AAN model states targeted testing (e.g., Fragile X) should be negative if indicated prior to CMA; the patient had Fragile X testing previously and it was nondiagnostic, meeting that prior test requirement.",Not Specified,"The policy references family testing in the context of evaluating biological relatives of a child/fetus with abnormal CMA, but it does not define family-history criteria (e.g., cancer in a relative) as an indication for CMA; the patient's family history (aunt with breast cancer) is not specified as relevant in the policy.",Yes,"The policy strongly recommends pre-test genetic counseling and AAN model coverage requires face-to-face counseling; the patient received pre-test counseling with a genetic specialist and planned post-test follow-up, meeting counseling requirements.",81228,"Policy lists CPT 81228 for genome-wide cytogenomic analysis (CGH microarray), which corresponds to the requested CMA.",No,"Although counseling and prior Fragile X testing requirements are met, UnitedHealthcare policy limits CMA coverage to specified indications (ASD, DD/ID, multiple congenital anomalies not part of a well-delineated syndrome, or isolated severe CHD). The provided facts describe a single-organ congenital anomaly without documentation of DD/ID, ASD, multiple anomalies, or severe CHD; therefore the request does not meet the policy's listed medical necessity criteria.",30417,2541,32958
Case3465,rag,all_correct,iter2,WGS,Patient information states whole genome sequencing (WGS) has been ordered.,Yes,"Policy lists global developmental delay and intellectual disability with onset before 18 years as qualifying features for WGS; the patient is a 2-year-old with developmental delay/ID, meeting the age-related criteria.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient is being evaluated by and WGS was ordered by a medical geneticist.",Yes,"Policy indicates WGS is medically necessary when presentation is nonspecific and one qualifying feature (e.g., global developmental delay or intellectual disability) is present; the patient has nonspecific developmental delay/ID without a specific syndrome.",Yes,"Policy criterion for WGS states 'Neither CMA nor WES have been performed.' Patient history notes only nondiagnostic Fragile X testing and no prior CMA or WES, satisfying this requirement.",No,"Policy’s family-history criteria refer to consanguinity or first/second-degree relatives with similar clinical features; the patient’s family history is paternal long QT syndrome, which is not a similar neurodevelopmental phenotype or consanguinity.",Yes,"Policy 'strongly recommends' genetic counseling prior to WGS; patient had pre-test counseling with a genetic counselor and plans for post-test counseling, meeting counseling expectations.",81425,Policy applicable CPT codes list 81425 for genome (sequence analysis) which corresponds to WGS for the proband.,Yes,"All policy coverage criteria for WGS are met: clinical presentation nonspecific (no specific syndrome), qualifying feature present (global developmental delay/ID), ordered by a medical geneticist, and neither CMA nor WES have been performed; genetic counseling was provided.",36943,1747,38690
Case15557,rag,all_correct,iter2,WGS,Patient info explicitly states whole genome sequencing (WGS) is being performed.,Yes,"Policy age-related criteria (e.g., features diagnosed by age 18) apply to some indications; the patient is 15, which satisfies any 'diagnosed by 18 years' requirements in the WGS policy.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was referred by/ordered via neurology so the ordering provider type meets policy requirements.",Yes,Policy requires a clinical history suggesting a genetic cause plus either specific major criteria or two or more listed features. Patient has a congenital anomaly and another first-degree family member (sibling) with similar features — meeting the 'two or more features' clinical criterion.,Yes,"Policy states WGS is appropriate when 'neither CMA nor WES have been performed.' Patient has prior FISH (nondiagnostic) and no documentation of prior CMA or WES, meeting the policy prior-test requirement for WGS.",Yes,Policy lists 'other first- or second-degree family member(s) with similar clinical features' as an eligibility feature; patient has a sibling with a similar congenital anomaly.,Not Specified,Policy 'strongly recommends' genetic counseling prior to WES/WGS but does not make counseling an explicit coverage prerequisite; patient has had multiple genetic counseling visits (meets recommendation) but counseling is not specified as a strict requirement for coverage.,81425,"Applicable codes list in the policy identifies 81425 as the CPT code for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' (primary WGS code).",Yes,All policy coverage criteria for WGS are met: ordering provider is an allowed specialty (neurologist); clinical criteria met (congenital anomaly + affected first-degree relative suggesting genetic cause); neither CMA nor WES documented as performed; patient age is within policy considerations. Therefore WGS is medically necessary per the UnitedHealthcare policy.,36940,2830,39770
Case4982,rag,all_correct,iter2,WES,Patient is being considered for whole exome sequencing per the clinical note ('being considered for whole exome sequencing (WES)').,Yes,"Policy includes age‑based feature thresholds (e.g., diagnoses by age 18, epileptic encephalopathy onset <3). The patient is 11 years old (pediatric) and therefore within applicable age-based criteria where specified.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient was referred by a developmental pediatrician, satisfying the ordering‑provider requirement.",Yes,"Policy allows WES when clinical history suggests a genetic cause and two or more listed features are present. The patient has a congenital anomaly (Hirschsprung disease) and a first‑degree relative (sibling) with early epileptic encephalopathy, meeting the 'two or more features' criterion.",Not Specified,"The policy does not mandate specific prior testing (e.g., CMA/karyotype) prior to WES in non‑prenatal cases; it only advises targeted testing if a specific syndrome is suspected. The patient had prior nondiagnostic FISH, but the policy does not list mandatory prior tests for WES.",Yes,"Policy lists 'other first‑ or second‑degree family member(s) with similar clinical features' (and consanguinity) as a criterion. The patient has a sibling with epileptic encephalopathy (first‑degree relative), which is relevant.",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS. The family has met with a genetic counselor multiple times for pre‑test counseling and planned post‑test counseling, satisfying the counseling expectation.",81415,"Policy's Applicable Codes list CPT 81415 for exome (sequence analysis), which corresponds to WES.",Yes,"Under the policy WES is medically necessary when ordered by an approved specialist and the clinical history suggests a genetic cause with required features. The test is ordered by a developmental pediatrician, the presentation is nonspecific, and the patient meets criteria (congenital anomaly + affected first‑degree relative), so coverage is supported.",36969,3112,40081
Case14371,rag,all_correct,iter2,WES,Patient information states the general pediatrician ordered whole exome sequencing (WES).,Yes,"Policy age-related criteria include pediatric-onset features (e.g., intellectual disability or developmental delay diagnosed by age 18). The patient is 11 years old, which meets the policy's age-related constraints for pediatric WES indications.",No,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is a general pediatrician, which does not meet the policy's specified ordering-provider requirement.",No,"Policy coverage requires either (a) one of specified major pediatric features (e.g., moderate/severe ID, global developmental delay, epileptic encephalopathy) or (b) two or more listed features (one of which is autism spectrum disorder). The patient has autism spectrum disorder but no documented second qualifying feature (e.g., global developmental delay, intellectual disability, epilepsy) in the record, so the defined medical-indication criteria are not met per the policy.",Not Specified,"The policy does not mandate specific prior tests (e.g., CMA or Fragile X) prior to WES in the general pediatric neurodevelopmental context; it only states targeted testing should precede WES if a specific syndrome is suspected. Fragile X was done but the policy does not explicitly require it before WES.",No,"The policy specifies family-history criteria as 'other first- or second-degree family member(s) with similar clinical features.' The patient has a maternal aunt with a severe immunologic disorder, but this is not documented as having similar clinical features to the proband's neurodevelopmental/ASD phenotype, so the family-history criterion for WES eligibility is not met.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES but does not make counseling a strict coverage requirement. The patient did meet the recommendation (pre-test counseling occurred), but counseling is not specified as a mandatory eligibility criterion in the policy.",81415,"Per the policy's applicable CPT codes, 81415 corresponds to 'Exome; sequence analysis' (proband), which matches the requested WES.",No,"Per the UnitedHealthcare WES policy, all required criteria must be met (including ordering-provider specialty and defined clinical indication thresholds). The ordering provider is a general pediatrician (not one of the listed specialties), and the patient documents only autism spectrum disorder without a second qualifying feature or one of the policy's major pediatric features (e.g., global developmental delay or ID), so the policy criteria for medically necessary coverage are not satisfied.",36945,3203,40148
Case15202,rag,all_correct,iter2,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing per the clinical information; policy (FEP 2.04.02) addresses BRCA1/BRCA2 testing.,No,"The policy specifies age-based thresholds for qualifying personal history of breast cancer (e.g., diagnosed ≤45 years, 46–50 with additional features, ≤60 for triple-negative, etc.). The patient is 65 and her diagnosis is malignant phyllodes tumor (not listed in the policy as a qualifying breast cancer type), so she does not meet the policy's age-related/diagnosis-based criteria.",Yes,"Policy requires testing be performed in a setting with suitably trained providers who can give appropriate pre- and post-test counseling. The patient had pre-test counseling with a genetic specialist and plans post-test follow-up, meeting the policy's provider/counseling setting requirement.",No,"Policy defines specific medical indications for BRCA1/2 testing in cancer-affected individuals (specific breast cancer types/ages, ovarian, pancreatic, prostate, known familial pathogenic variant, etc.). The patient has a malignant phyllodes tumor (not listed as a qualifying cancer in the policy) and no reported qualifying family history, so she does not meet any of the policy-defined indications.",Not Specified,"The policy recommends testing an affected family member first when possible and describes testing strategies, but it does not mandate completion of a specific prior test in this patient; no required prior diagnostic test is specified for this scenario.",No,"The policy specifies family-history criteria (close blood relatives with breast/ovarian/pancreatic/prostate cancer, etc.) as qualifying. The patient's reported family history (a sister with an immunologic/hematologic disorder) does not meet the policy's specified cancer-family-history criteria.",Yes,"The policy requires genetic counseling by experienced providers for testing. The patient completed pre-test counseling with a genetic specialist and has plans for post-test follow-up, satisfying the counseling requirement in the policy.",Not Specified,The provided FEP policy (2.04.02) does not list or map CPT codes to BRCA1/BRCA2 testing; no CPT guidance is given in the policy text supplied.,No,"Per the policy's medical necessity criteria for BRCA1/2 testing, the patient does not meet any listed qualifying indications (her tumor type—malignant phyllodes—is not listed as qualifying breast cancer, she has no qualifying family cancer history, and does not meet age-related qualifying diagnosis criteria). Although counseling requirements are met, lack of meeting the policy's defined indications means the test is not covered.",18954,3144,22098
Case8621,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) is being performed to seek a unifying diagnosis.,Yes,"Patient is 2 years old; the policy’s WES indications include pediatric-onset criteria (e.g., global developmental delay with onset prior to 5 years and intellectual disability diagnosed by age 18). The patient’s age (2) satisfies those age-based thresholds in the policy.",No,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The test was ordered by the child’s oncologist, who is not among the listed authorized ordering providers.",Yes,"Policy lists neurodevelopmental disorders/autism as qualifying features for WES (autism spectrum disorder is among listed features supporting WES). The patient has a complex neurodevelopmental disorder with autism and is being evaluated after nondiagnostic CMA, meeting the clinical indication in the policy.",Not Specified,"The policy does not mandate a specific prior test (e.g., CMA) as a universal prerequisite for WES in non‑prenatal cases. The patient did have prior CMA that was nondiagnostic, but the policy does not require a specific prior test be completed before WES.",Yes,"Policy lists family history (other first- or second-degree family members with similar clinical features) and consanguinity as relevant features. The family reports an uncle with a congenital anomaly (a second-degree relative), which constitutes a relevant family history per the policy.",Yes,"The policy states genetic counseling is strongly recommended prior to WES/WGS. The family reports multiple meetings with a genetic counselor and that pre-test counseling was completed with plans for post-test follow-up, satisfying the counseling recommendation.",81415,The policy's applicable CPT codes list 81415 for exome (sequence analysis) for a proband; this best corresponds to the requested WES for the child.,No,"Although the patient’s clinical presentation (neurodevelopmental disorder with autism), age, prior nondiagnostic CMA, family history, and completed genetic counseling align with the policy’s clinical indications for WES, the policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is an oncologist, so the ordering-provider requirement is not met and coverage is not supported under the policy.",36950,3022,39972
Case14141,rag,all_correct,iter2,WES,Patient info states 'whole exome sequencing (WES) is planned' — explicitly requests WES.,Yes,"Policy criteria apply to 'children' with unexplained congenital or neurodevelopmental disorders; patient is 7 years old, meeting the pediatric ('children') age criterion in the policy.",Not Answerable,"Policy requires 'documentation that the individual has been evaluated by a clinician with expertise in clinical genetics' (Policy Statement #1). Patient info documents referral by an oncologist and that pre-test genetic counseling was completed, but does not state the patient was evaluated by a clinician with expertise in clinical genetics; insufficient information to determine if ordering/provider requirement is met.",Yes,"Policy deems WES medically necessary for children with unexplained congenital anomalies or neurodevelopmental disorders following standard workup. Patient has multiple congenital anomalies and suspected genetic etiology, matching that medical indication.",Yes,"Policy expects prior genetic testing (eg, chromosomal microarray) to have been performed or failed. Patient had prior CMA testing reported as nondiagnostic, satisfying the prior-test requirement described in the policy.",Yes,"Policy lists family history of developmental delay as relevant. Patient has a sibling with global developmental delay, which is a relevant family history per the policy.",Yes,"Policy requires counseling as part of the evaluation. Patient information states pre-test genetic counseling was completed and arrangements for post-test counseling/follow-up were made, meeting the counseling requirement.",Not Specified,The provided policy text does not specify CPT/billing codes for WES; no CPT mapping is given in the document.,No,"Although the patient meets the clinical indications (multiple congenital anomalies), has nondiagnostic CMA, is pediatric, has relevant family history, and has had pre-test genetic counseling, the policy requires documentation that the individual 'has been evaluated by a clinician with expertise in clinical genetics' as part of the ALL criteria for WES. The patient record supplied does not document evaluation by a clinician with expertise in clinical genetics; therefore not all required policy criteria are documented and coverage cannot be confirmed under the policy.",14836,2130,16966
Case6747,rag,all_correct,iter2,WGS,Patient info states whole genome sequencing (WGS) was ordered by the medical geneticist.,No,"Policy allows rapid WGS/WES only for critically ill infants in NICU/PICU; for other situations whole genome sequencing is stated as investigational. The patient is a 12-year-old who is not a critically ill infant, so age/acuity-based eligibility for WGS is not met (Policy Statement: rapid WGS for critically ill infants; 'Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations').",Yes,"Policy criterion #1 requires evaluation by a clinician with expertise in clinical genetics and counseling; the test was ordered by a medical geneticist, meeting the ordering-provider requirement.",No,"Policy defines medical indications for WGS only as rapid testing in critically ill infants; the patient (12-year-old, not critically ill) does not meet those WGS-specific clinical criteria. (Policy Statement: rapid WGS/WES medically necessary for critically ill infants; otherwise WGS investigational.)",Yes,"Policy expects prior standard workup (eg, chromosomal microarray analysis) before sequencing; the record states CMA was previously performed and nondiagnostic, satisfying required prior testing per policy guidelines.",Yes,"Policy lists family history of developmental delay as relevant; the family reports a sibling with developmental delay, which is a relevant family history per Policy Guidelines.",Yes,"Policy requires genetic counseling and documentation; the patient had pre-test counseling completed and post-test counseling planned, meeting the counseling requirement (Policy Statement #1 and 'Genetic Counseling' section).",Not Specified,The provided policy document does not list or map CPT codes to WGS/WES services; no CPT guidance is present in the policy text supplied.,No,"Although the patient meets many WES criteria (child with multiple congenital anomalies, CMA nondiagnostic, evaluated by geneticist, counseling done), the requested test is WGS. The policy states 'Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations' (except rapid WGS for critically ill infants). Because this patient is a non-critically ill 12-year-old, WGS is investigational and not covered under the policy.",14819,2997,17816
Case811,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued.,Not Specified,The policy refers to 'children' and to infants for rapid testing but gives no explicit numeric age cutoff; therefore no specific age-based eligibility criterion is specified.,Not Answerable,"Policy requires documentation that the individual was evaluated by a clinician with expertise in clinical genetics and counseled. Patient notes pre-test counseling by a genetic counselor and referral by a pediatrician, but it is not explicitly documented whether a clinician with expertise in clinical genetics performed the required evaluation.",Yes,"Policy permits WES for children with unexplained congenital or neurodevelopmental disorders when prior testing is nondiagnostic. The infant has early-onset movement abnormalities concerning for a genetic movement disorder and CMA was nondiagnostic, meeting the clinical indication.",Yes,"Policy criteria require prior genetic testing (eg, chromosomal microarray) or failure of prior testing. The patient had a chromosomal microarray (CMA) previously performed and reported as nondiagnostic.",Yes,"Policy guidance cites relevant family history (eg, multiple congenital anomalies in a sibling) as supporting use of WES. The patient has a positive family history in an older sibling with multiple congenital anomalies.",Yes,Policy requires counseling about potential risks and recommends genetic counseling by an individual with expertise. The patient completed pre-test counseling with a genetic counselor and post-test follow-up is planned.,Not Specified,The provided policy document does not specify or map specific CPT codes to WES; no CPT guidance is given in the text.,Yes,"Based on the policy, WES may be considered medically necessary for children with unexplained congenital/neurodevelopmental disorders when all criteria are met. The patient is an infant with early-onset movement disorder, prior nondiagnostic CMA, relevant family history, pre-test genetic counseling, and potential for change in management—consistent with the policy's medical necessity criteria.",14871,3187,18058
Case7604,rag,all_correct,iter2,WGS,Patient info explicitly states whole genome sequencing (WGS) has been ordered.,Yes,"Policy age restrictions do not exclude neonates and the covered WGS indications include congenital anomalies (no minimum age); the patient is a neonate with multiple congenital anomalies, so age-based requirements are met.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neurologist, which meets the requirement.",Yes,"Policy lists 'multiple congenital anomalies (must affect different organ systems)' as an accepted indication for WGS; the neonate has multiple congenital anomalies affecting several organ systems, satisfying medical necessity criteria.",Yes,"Policy requires that neither CMA nor WES have been performed before WGS; patient had prior FISH (nondiagnostic) but no CMA or WES documented, so prior-test requirement is satisfied.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' as a supporting feature; the patient has an older sibling with multiple congenital anomalies, meeting the family-history criterion.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WGS but does not make counseling a mandatory coverage criterion; the family declining counseling does not, per policy text, automatically deny coverage.",81425,"Policy's applicable CPT codes list 81425 for genome (sequence analysis), which corresponds to WGS.",Yes,"All written WGS coverage criteria are met per the policy: ordered by an allowed specialist (neurologist), clinical presentation includes multiple congenital anomalies affecting different organ systems, and neither CMA nor WES has been performed; therefore WGS is covered.",36935,1799,38734
Case950,rag,all_correct,iter2,WES,Patient information states whole exome sequencing (WES) is being pursued to evaluate unexplained epileptic encephalopathy.,Yes,"Policy lists 'epileptic encephalopathy with onset before three years of age' as an indication for WES; patient’s seizures began before age 3, so the age-related onset criterion is met (policy Coverage Rationale).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient’s WES is ordered while evaluated by a medical geneticist (policy Coverage Rationale).",Yes,"Policy requires a nonspecific clinical presentation and one qualifying feature such as 'epileptic encephalopathy with onset before three years of age.' Patient has unexplained epileptic encephalopathy with onset <3 years and nonspecific phenotype, meeting the medical indication (policy Coverage Rationale).",Not Specified,Policy only indicates targeted single-gene/panel testing if a specific syndrome is suspected; it does not mandate prior epilepsy multigene panel testing for nonspecific epileptic encephalopathy. Patient has prior nondiagnostic karyotype but no universal prior-test requirement is specified for this scenario (policy Coverage Rationale).,No,"Policy cites family history/consanguinity (e.g., first/second-degree relatives with similar features or consanguinity) as relevant criteria. Patient’s family history (an uncle with prostate cancer) is not a first/second-degree relative with similar neurologic features and no consanguinity is reported, so relevant family-history criteria are not met (policy Coverage Rationale and Definitions).",Yes,"Policy 'strongly recommends' genetic counseling prior to WES/WGS. Patient has seen a genetic counselor multiple times and has plans for post-test counseling, satisfying the counseling recommendation (policy Description of Services).",81415,CPT code 81415 corresponds to 'Exome; sequence analysis' listed in the policy as the appropriate code for WES (policy Applicable Codes).,Yes,"All required coverage criteria in the policy are met: WES ordered by a medical geneticist, nonspecific presentation, and qualifying feature 'epileptic encephalopathy with onset before three years of age.' Therefore WES is proven and medically necessary per the policy (policy Coverage Rationale).",36974,1802,38776
Case17822,rag,all_correct,iter2,WGS,Patient information states that whole genome sequencing (WGS) has been ordered as the next-tier diagnostic test.,Yes,"Patient is 13 years old. Policy criteria reference features diagnosed by age 18 (e.g., ID, hearing/vision impairment) and include pediatric presentations such as multiple congenital anomalies — the patient's age fits the pediatric/age-related criteria.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the order was placed by a medical geneticist.",Yes,"Policy clinical criteria for WGS include 'multiple congenital anomalies (must affect different organ systems)'; the patient has multiple congenital anomalies affecting different organ systems, meeting the clinical indication (per the policy).",No,"Policy WGS criteria state all of the following must be met including 'Neither CMA nor WES have been performed.' The patient has a nondiagnostic CMA performed prior to WGS, so the policy's prior-test requirement for WGS is not met.",No,"Policy lists consanguinity or 'other first- or second-degree family member(s) with similar clinical features' as family-history criteria. The family history notes a sibling with short stature, which is not documented as similar multisystem congenital anomalies or consanguinity per the provided facts.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not make counseling a stated coverage requirement; the patient declined counseling, but counseling is not specified as mandatory for coverage in the policy.",81425,"Policy's applicable CPT codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' which corresponds to WGS.",No,"Although the patient meets clinical indications (multiple congenital anomalies) and the ordering provider and age criteria align with policy, the WGS coverage criteria require that 'Neither CMA nor WES have been performed.' The patient had a nondiagnostic CMA prior to WGS, so the specific WGS coverage requirements in the policy are not satisfied; therefore WGS is not covered per the policy.",36947,2523,39470
Case9408,rag,all_correct,iter2,WES,Patient information states the 17-year-old is undergoing whole exome sequencing (WES) requested by a medical geneticist for evaluation of epileptic encephalopathy.,Yes,Policy medical-necessity statements apply to 'children' with neurodevelopmental disorders; the patient is 17 years old (a child under the policy) and therefore meets the age-related application of the WES policy.,Yes,"Policy criterion #1 requires evaluation by a clinician with expertise in clinical genetics and counseling; the test was ordered by a medical geneticist and pre-test counseling was completed, satisfying ordering provider requirements in the policy.",Yes,"Policy covers WES for children with unexplained congenital or neurodevelopmental disorders; the patient has epileptic encephalopathy with onset before age 3, which is a neurodevelopmental disorder consistent with the policy's clinical indications.",Yes,"Policy requires prior genetic testing (e.g., chromosomal microarray) to have failed to yield a diagnosis; the patient had CMA previously performed and nondiagnostic, meeting the prior-test criterion.",No,"The policy lists specific family-history examples relevant to selection for sequencing (eg, developmental delay, inborn errors). The patient has a maternal history of immunologic/hematologic disorder which is not among the policy's listed relevant family-history examples; thus the patient's family history does not match the policy examples.",Yes,"Policy requires counseling by an individual with genetic expertise; the patient completed pre-test counseling and plans post-test follow-up with a genetic counselor, meeting the counseling requirement.",Not Specified,The provided FEP policy document does not list or map specific CPT codes to WES; no CPT code guidance is included in the text supplied.,Yes,"Per the policy, standard WES may be considered medically necessary for children with unexplained neurodevelopmental disorders when all criteria are met. The patient (age 17) has early-onset epileptic encephalopathy, was evaluated by a medical geneticist, had nondiagnostic CMA, and received pre-test counseling — meeting the policy's required criteria for coverage.",14851,2387,17238
Case3592,rag,all_correct,iter2,CMA,Patient information explicitly requests chromosomal microarray (CMA) testing. Basis: patient note and policy target test is CMA.,Not Specified,The CMA guideline addresses prenatal and postnatal use but does not impose age-based eligibility limits. Basis: policy criteria do not specify age restrictions.,Not Specified,"The policy requires pre- and post-test genetic counseling and that the rendering lab be qualified, but it does not specify ordering provider specialty/credentials. Basis: policy text lacks explicit ordering-provider specialty requirements.",No,"Policy defines specific symptomatic indications (postnatal: no prior CMA, testing on living child/adult, diagnosis not by clinical exam alone, and one of DD/ID, ASD, major cardiac anomaly, or multiple congenital anomalies). The neonate's primary indication (neonatal epileptic encephalopathy) is not among the listed presentations. Basis: CMA criteria list in policy.",No,"Policy requires 'No previous CMA testing' for diagnostic postnatal CMA. Patient had a prior chromosomal microarray (nondiagnostic), so the required prior-test condition is not met. Basis: 'No previous CMA testing' criterion and billing: 'CMA is only reimbursable once per lifetime.'",No,"Policy specifies an exclusion related to family history of a chromosome rearrangement in phenotypically normal individuals. The patient has a sibling with developmental regression, but no family history of a known chromosome rearrangement is reported, so the specific family-history criterion/exclusion does not apply. Basis: CMA exclusions in policy.",Yes,"Policy requires pre- and post-test genetic counseling by an appropriate provider. Patient information states pre-test counseling was discussed with a genetic specialist and post-test follow-up is planned, satisfying this requirement. Basis: 'Genetic Counseling' requirement in policy.",81228,Policy lists CPT 81228 for chromosomal microarray (constitutional BAC/array) as the relevant procedure code. Basis: procedure codes table in policy.,No,"Coverage criteria require no prior CMA and the billing section states CMA is reimbursable only once per lifetime. The patient had a prior CMA (nondiagnostic), so the request does not meet the policy's required criteria for coverage. Basis: 'No previous CMA testing' and 'CMA is only reimbursable once per lifetime' in the policy.",10103,1929,12032
Case17929,rag,all_correct,iter2,CMA,Patient information states 'tumor chromosomal microarray (CMA) testing has been requested'; policy is the CMA policy. Basis: patient request text.,Not Specified,"The UnitedHealthcare CMA policy does not impose an age limit for postnatal CMA; coverage criteria are indication-based (e.g., DD/ID, congenital anomalies) rather than age-specific.",Not Specified,The policy strongly recommends pre-test genetic counseling and expertise for interpretation but does not state a required ordering provider specialty or limit who may order CMA.,Yes,"Policy lists CMA as proven/medically necessary for evaluation of congenital/multiple anomalies and for evaluation when karyotype is nondiagnostic. Patient has a major abnormality affecting ≥1 organ system and prior karyotype was nondiagnostic, which meets the policy indications.",Not Specified,"The policy does not mandate specific prior tests universally (CMA is often first-tier); although the patient had a nondiagnostic karyotype (supportive), the policy does not require completion of particular prior testing as a universal precondition.",Not Specified,Policy does not define CMA eligibility based on family history of BRCA1/2; the noted maternal BRCA1/2 pathogenic variant is unrelated to the CMA coverage criteria in the policy.,Yes,"Policy 'strongly recommends' pre-test genetic counseling and AAN/SMFM/ACMG guidance support counseling; patient completed multiple pretest counseling sessions with a genetic counselor and plans post-test follow-up, meeting counseling expectations in the policy.",81228,Policy's Applicable Codes list CPT 81228 as 'Cytogenomic (genome-wide) analysis... comparative genomic hybridization [CGH] microarray analysis' which corresponds to CMA requested.,Yes,"Based on policy coverage rationale, CMA is medically necessary for evaluation of congenital/organ-system anomalies and when karyotype is nondiagnostic. Patient has a major organ-system abnormality, prior nondiagnostic karyotype, and documented pre-test counseling — meeting policy criteria for coverage.",30400,2313,32713
Case12834,rag,all_correct,iter2,CMA,Patient record states chromosomal microarray (CMA) testing was ordered (requisition specifies a tumor-type assay).,Not Specified,The Cigna policy for chromosomal microarray for solid tumors (MOL.TS.344.A) does not include any age-based eligibility criteria.,Not Specified,Policy specifies the rendering laboratory must be a qualified provider per Health Plan policy but does not define ordering provider specialty or other ordering-provider requirements.,No,"Policy medical necessity requires the member be diagnosed with CNS cancer or soft tissue sarcoma; the patient has a neurodevelopmental disorder with no documented diagnosis of CNS cancer or soft tissue sarcoma, so the clinical indication in policy is not met.",Not Specified,The policy does not list required prior tests that must be completed before CMA for solid tumors.,Not Specified,The CMA-for-solid-tumors policy does not include family history or consanguinity as eligibility criteria; the patient’s family history is therefore not addressed by the policy.,Not Specified,The policy discusses laboratory reporting and potential germline findings but does not mandate or specify pre-test genetic counseling requirements for this assay.,81277,The policy's procedure table and text list cytogenomic neoplasia microarray analysis with CPT code 81277 for chromosomal microarray of solid tumors.,No,"Per the policy, CMA on solid tumor tissue is medically necessary only for members diagnosed with CNS cancer or soft tissue sarcoma and performed by a qualified lab; this patient (16-year-old with a neurodevelopmental disorder and no documented CNS cancer or soft tissue sarcoma) does not meet the policy's coverage criteria.",6182,1214,7396
Case4604,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) is being requested to evaluate developmental delay/intellectual disability.,Yes,"Policy applies to children with unexplained neurodevelopmental disorders; the patient is a 6‑year‑old child, so age meets the 'children' eligibility in the policy.",Yes,"Policy requires documentation of evaluation by a clinician with expertise in clinical genetics and counseling. Patient has completed pre‑test counseling with a genetic counselor and has documented family history and phenotype, satisfying the policy's evaluation/counseling requirement.",Yes,Policy lists unexplained neurodevelopmental disorders/developmental delay/intellectual disability in children as an indication for WES. Patient has unexplained developmental delay and intellectual disability.,Yes,"Policy criteria include prior genetic testing (eg, CMA) failed to yield a diagnosis. Patient had prior chromosomal microarray (CMA) testing that was nondiagnostic.",Yes,"Policy notes family history of developmental delay as relevant. Patient has an older sibling with moderate–severe intellectual disability, which is a relevant family history per the policy.",Yes,"Policy requires genetic counseling by an experienced provider. Patient completed pre‑test counseling with a genetic counselor and has plan for post‑test follow‑up, meeting the counseling requirement.",Not Specified,The provided BCBS_FEP policy text does not list or map specific CPT codes to WES; thus a CPT code is not specified in the policy document.,Yes,"All required policy criteria are met: child with unexplained neurodevelopmental disorder (developmental delay/ID), prior CMA nondiagnostic, documented family history, and pre‑test genetic counseling — therefore WES may be considered medically necessary per the policy.",14848,2315,17163
Case8661,rag,all_correct,iter2,WGS,Patient information states 'whole genome sequencing (WGS) is requested.',Yes,"Policy age-related language allows features 'diagnosed by 18 years of age'; patient is 7 years old, which meets the age-related requirement in the WGS criteria.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; patient was referred by the child's neurologist, which meets this provider requirement.",No,"Policy requires either (A) the proband to have epileptic encephalopathy onset <3 years or (B) two or more listed features (e.g., significant hearing/visual impairment plus a second listed feature). The patient has significant hearing/visual impairment (1 feature) and a sibling with epileptic encephalopathy (family history) but does not have two of the second-list features or the proband-level epileptic encephalopathy required by the first-list criterion, so the specified medical indication for WGS is not met per the policy.",Yes,"Policy for WGS requires that neither CMA nor WES have been performed; patient previously had Fragile X testing only and has not had CMA or WES, satisfying the prior-test requirement for WGS.",Yes,"Patient has a first-degree family history (sibling) of epileptic encephalopathy before age 3; the policy lists 'other first- or second-degree family member(s) with similar clinical features' as a relevant feature, so a pertinent family history is present.",Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WGS/WES but does not define genetic counseling as a strict coverage requirement; thus counseling requirements for coverage are not specified as mandatory.,81425,Policy Applicable Codes map genome sequence analysis (whole genome sequencing) to CPT code 81425.,No,"Although age, ordering provider, and prior-test conditions are met (Q1,Q2,Q4), the policy's medical necessity criteria for WGS require either the proband to have epileptic encephalopathy onset <3 years or two or more listed clinical features in the proband. The patient only has one proband feature (significant hearing/visual impairment) and the sibling's epilepsy does not satisfy the proband-level feature requirement; therefore the request does not meet the policy's clinical indication for coverage.",36963,3728,40691
Case6451,rag,all_correct,iter2,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,Yes,"Policy age-related features include 'hypotonia in infancy' and other pediatric criteria; the patient is a 7‑week‑old infant with hypotonia, meeting the age-related criteria in the WGS coverage rationale.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering clinician is a developmental pediatrician, satisfying this requirement.",Yes,"Policy requires nonspecific presentation plus one listed feature (or two of a list); the infant has significant hypotonia in infancy (a listed feature) and a nonspecific presentation, meeting the medical indication for WGS.",Yes,"Policy states WGS is appropriate when 'Neither CMA nor WES have been performed.' The patient had a nondiagnostic karyotype but no CMA or WES reported, satisfying the prior test criterion.",Yes,"Policy lists family history and 'persistent and severe immunologic or hematologic disorder' among relevant features; the mother has a history of a persistent severe immunologic/hematologic disorder, representing relevant family history.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling an explicit mandatory coverage requirement; patient did have pre-test counseling, but the policy language is recommendation rather than a required criterion.",81425,"Policy lists CPT 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to WGS.",Yes,"All policy coverage criteria for WGS are met: ordered by an allowed provider (developmental pediatrician), presentation nonspecific with a listed feature (hypotonia in infancy), no prior CMA/WES performed, and family history supportive; therefore WGS is medically necessary per the policy.",36937,2027,38964
Case19255,rag,all_correct,iter2,BRCA1/2,Patient was referred for BRCA1/2 testing to evaluate hereditary breast/ovarian cancer predisposition — request explicitly states BRCA1/2.,Yes,Policy: 'BRCA1/2 gene testing is proven and medically necessary for individuals with a personal history of Breast Cancer diagnosed at age 65 or younger.' Patient is 38 and meets this age criterion.,Not Specified,Policy strongly recommends pre-test genetic counseling and involvement of clinicians familiar with hereditary cancer but does not mandate a specific ordering provider specialty; no strict ordering-provider requirement is specified.,Yes,"Policy coverage: BRCA1/2 testing is medically necessary for individuals with a personal history of breast cancer (including multiple primary breast cancers). Patient has two separate primary breast cancers, meeting the clinical indication.",Not Specified,"Policy does not require specific prior testing (e.g., tumor testing or other diagnostic tests) as a prerequisite for BRCA1/2 germline testing; no required prior tests are specified for this indication.",Yes,"Policy lists BRCA-related cancers to include prostate cancer and includes family-history-based criteria; patient has a first-degree relative (father) with metastatic prostate cancer, which is relevant to BRCA testing eligibility.",Not Specified,"Policy 'strongly recommends' pre-test genetic counseling but does not make counseling an explicit mandatory coverage condition; although the patient completed pre-test counseling, the policy does not define counseling as a required coverage criterion.",81162,Policy Applicable Codes: CPT 81162 = BRCA1/BRCA2 full sequence analysis and full duplication/deletion analysis; this corresponds to comprehensive BRCA1/2 testing requested.,Yes,"Per UHC policy, BRCA1/2 testing is proven and medically necessary for individuals with personal history of breast cancer diagnosed ≤65; patient is 38 with two primary breast cancers and relevant family history, thus meeting coverage criteria.",38613,1521,40134
Case2211,rag,all_correct,iter2,BRCA1/2,The patient was referred specifically for BRCA1 and BRCA2 testing per the clinical information.,Not Specified,"Policy age-based criteria are specified for BRCA1/2 testing in the context of a personal history of breast cancer (e.g., ≤65), but for this scenario (known familial BRCA2 pathogenic variant / single-gene familial testing) the policy does not impose an age restriction; no applicable age eligibility requirement is specified for known familial mutation testing.",Not Specified,"The policy encourages/strongly recommends pre-test genetic counseling and involvement of genetics professionals, but it does not state a specific required ordering provider specialty or restrict who may order BRCA1/2 testing.",Yes,Policy states single-gene testing and known mutation testing for familial cancer is proven and medically necessary and that testing is clinically indicated when an individual has a blood relative with a known pathogenic/likely pathogenic variant; the patient’s mother carries a known BRCA2 pathogenic variant.,Not Specified,The policy does not require prior testing before single-gene/known familial mutation BRCA1/2 testing in this scenario; no specific prior tests are defined as required.,Yes,"Family history criteria are specified in the policy and the patient reports a mother with a known BRCA2 pathogenic variant and additional affected relatives on the same side of the family, meeting family-history criteria.",Yes,"Policy 'strongly recommends' pre-test genetic counseling; the patient completed pre-test counseling with a genetic specialist and plans post-test follow-up, satisfying the counseling recommendation.",81162,"Applicable codes in the policy list 81162 for BRCA1/BRCA2 full sequence analysis plus full duplication/deletion analysis, which corresponds to comprehensive BRCA1/2 testing as requested.",Yes,"Under the policy, single-gene testing/known mutation testing for familial cancer is medically necessary and testing is clinically indicated when an individual has a blood relative with a known pathogenic variant — the patient’s mother has a known BRCA2 pathogenic variant, so testing is covered.",38641,2255,40896
Case18882,rag,all_correct,iter2,WES,Patient information states whole exome sequencing (WES) is being requested.,Not Specified,"The policy does not impose a specific age limit for WES for multiple congenital anomalies; age-related criteria in the policy (e.g., ID diagnosed by 18 years) are not applicable to this patient’s indication.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a developmental pediatrician, meeting the requirement.",Yes,Policy lists 'multiple congenital anomalies (must affect different organ systems)' as a specific indication for WES; the patient has multiple congenital anomalies affecting several organ systems.,Not Specified,The WES coverage criteria do not mandate specific prior tests for postnatal multisystem congenital anomalies (prenatal CMA/karyotype is required only for prenatal WES); prior FISH was nondiagnostic but no required prior test is specified for this indication.,No,"The policy includes family history/consanguinity as supportive criteria, but the patient does not have reported consanguinity or a first/second-degree relative with similar clinical features (mother has long QT, which is not described as similar to the child's multisystem congenital anomalies).",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make pre-test counseling a stated coverage requirement; the family declined pre-test counseling, which the policy recommends but does not require.",81415,Policy's applicable codes list 81415 for exome (sequence analysis) which corresponds to WES for the proband.,Yes,Coverage criteria are met: WES ordered by a developmental pediatrician and the patient has multiple congenital anomalies affecting different organ systems—an explicit covered indication in the policy.,36940,1629,38569
Case14408,rag,all_correct,iter2,BRCA1/2,Patient was referred for BRCA1/2 testing (document states referral for BRCA1/2 testing).,Yes,"Policy age requirement for BRCA analyses is 'Age 18 years or older' for relevant BRCA tests; the patient is 75, which meets this criterion.",Not Specified,The policy does not specify required ordering provider specialty/type for BRCA testing; it specifies pre/post-test genetic counseling by an appropriate provider but not a required ordering provider specialty.,Yes,"Policy allows predisposition testing when the member has a first-degree relative who meets 'Diagnostic Testing for Symptomatic Individuals' (male breast cancer is listed). The patient has a brother with breast cancer (first-degree relative), meeting the policy clinical indication.",Yes,"Policy requires no prior full BRCA1/2 sequencing (and no known family mutation) for full sequence testing; the patient has no prior genetic testing. Pre-test counseling was completed, meeting the counseling prerequisite.",Yes,"Policy criteria use family history; patient has a first-degree relative (brother) with breast cancer, a relevant family history per the guideline.",Yes,Policy requires pre- and post-test genetic counseling by an appropriate provider; the patient completed pre-test counseling and post-test follow-up with a genetic counselor is planned.,81162,Policy lists CPT 81162 for BRCA1/2 full sequencing plus deletion/duplication and states 81162 is likely most appropriate when sequencing and del/dup are performed concurrently; 'BRCA1/2 testing' in this context best corresponds to comprehensive testing (81162).,Yes,"Patient meets policy criteria: age ≥18, relevant family history (first-degree relative with male breast cancer), no prior BRCA testing, and required pre-test counseling completed—therefore BRCA testing is covered per the guideline.",10244,2597,12841
Case4262,rag,all_correct,iter2,WES,Patient was referred for diagnostic whole exome sequencing (WES) (stated explicitly).,Yes,"Policy applies to children/infants with congenital anomalies; the patient is a five-week-old infant, which meets the age scope in the policy for WES.",Yes,"Policy requires evaluation by a clinician with genetics expertise and counseling; the record states pre-test genetic counseling has been completed and genetics follow-up is planned, satisfying the provider/counseling requirement.",Yes,"Policy lists 'unexplained congenital anomalies' in children as an indication for WES; the patient has multiple congenital anomalies not fitting a well-delineated syndrome, matching this medical indication.",Not Specified,"Policy cites prior genetic testing (eg, CMA or targeted testing) as relevant but does not mandate a specific prior test; the patient had a nondiagnostic karyotype, but the policy does not explicitly require CMA or any particular prior test before WES.",Yes,"Policy lists family history items relevant to testing, including 'BRUE in sibling'; the patient’s family history includes a sibling with a BRUE.",Yes,Policy requires genetic counseling and evaluation by genetics expertise; patient information documents pre-test genetic counseling was completed and post-test genetics follow-up is planned.,81415,The requested test is whole exome sequencing; CPT 81415 corresponds to exome sequencing (clinical).,Yes,"Under the policy WES is medically necessary for children with unexplained congenital anomalies when all criteria are met: (1) genetics evaluation/counseling documented (met), (2) potential to change management (implicit in diagnostic evaluation for multiple congenital anomalies), and (3) prior genetic testing nondiagnostic (karyotype nondiagnostic). Therefore the request meets policy criteria for coverage.",14843,2710,17553
Case10363,rag,all_correct,iter2,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,Not Specified,"The policy does not impose a standalone age cutoff for WGS; age-limited items exist for certain features (e.g., ID by 18, seizure onset <3) but no general age exclusion applies to this 7-year-old.",No,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a general practitioner and does not meet the specified provider requirement.",No,"Policy requires either (a) clinical history plus one of: multiple congenital anomalies (multiple systems) or ID/global DD/early epileptic encephalopathy, or (b) clinical history plus two or more listed features. The patient has a single congenital anomaly since birth and no additional listed features; therefore clinical criteria for WGS are not met.",Yes,"Policy criterion for WGS states 'Neither CMA nor WES have been performed.' Patient had nondiagnostic FISH and there is no record of prior CMA or WES, satisfying that policy condition.",No,Policy lists consanguinity and first/second-degree relatives with similar clinical features as relevant family-history criteria. Patient’s family history (maternal aunt with pancreatic cancer) does not meet those specified family-history criteria.,Not Specified,"The policy 'strongly recommends' genetic counseling but does not state counseling as a required coverage criterion; although the patient has had pre-test counseling, counseling is not a defined mandatory coverage requirement in the policy.",81425,"Policy 'Applicable Codes' lists 81425 as the CPT code for Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis, corresponding to WGS.",No,"Coverage denial: per policy, WGS requires ordering by a specified specialist (medical geneticist, neonatologist, neurologist, or developmental pediatrician) and specific clinical criteria (e.g., multiple congenital anomalies or two or more listed features). The ordering provider is a general practitioner and the patient’s clinical presentation does not meet the policy’s required clinical indication, so WGS is not covered.",36961,2469,39430
Case9349,rag,all_correct,iter2,WES,Patient info explicitly states whole exome sequencing (WES) was ordered.,Yes,"Policy applies to children (pediatric) with unexplained congenital disorders; patient is a 5-year-old child, so age meets policy pediatric criteria.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling. The patient was referred for genetic evaluation, had pre-test counseling with a genetic counselor, and family history/phenotype were documented, satisfying the ordering/provider requirements in the policy.",Yes,"Policy medical-necessity criteria for WES include unexplained congenital disorders in children and either prior genetic testing failed or genetic etiology is most likely. The patient has an unexplained congenital cardiac anomaly and a nondiagnostic prior genetic test (FISH) with family history raising inherited etiology, meeting the policy's clinical indication.",Not Specified,"Policy references prior genetic testing (eg, CMA and/or targeted single-gene testing) as examples but does not mandate a specific prior test; patient had nondiagnostic FISH but the policy does not explicitly require CMA or other specific prior tests.",Yes,"Policy lists sudden unexplained death in first- or second-degree relatives before age 35 as relevant family history. The patient has a paternal uncle with sudden unexplained death before age 35, which matches the policy's relevant family history criteria.",Yes,"Policy states genetic counseling should be performed by someone with expertise; patient completed pre-test counseling with a genetic counselor and post-test follow-up plans are confirmed, meeting the policy counseling requirement.",81415,The requested test is whole exome sequencing (WES); CPT code 81415 corresponds to clinical exome sequencing.,Yes,"All policy-required elements for medically necessary WES are met: pediatric unexplained congenital anomaly, prior genetic testing nondiagnostic, relevant family history suggesting inherited etiology, documented counseling, and evaluation/referral for genetics — thus WES is covered per the FEP policy when all criteria are satisfied.",14843,2302,17145
Case1428,rag,all_correct,iter2,WGS,Patient information states whole genome sequencing (WGS) has been ordered.,Not Specified,"The policy does not impose an absolute age cutoff for WGS; age-related items in the policy refer to features (e.g., ID by 18, seizure onset <3 years) rather than an age eligibility limit, so no explicit age-based exclusion/requirement applies to this 3-week-old.",Yes,"Policy requires WGS to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a medical geneticist.",No,"Policy coverage for WGS requires clinical presentation nonspecific and one of the defined feature sets (e.g., multiple congenital anomalies or other combinations). The infant has a single-organ congenital anomaly (Hirschsprung) and a sibling with intellectual disability, but does not meet the policy's required feature combinations (e.g., multiple congenital anomalies or ≥2 listed features). Additionally the policy states if a specific/targeted gene test is available for a suspected syndrome, that targeted testing should be done prior to WGS.",Yes,"The policy requires that neither CMA nor WES have been performed prior to WGS; the record shows Fragile X testing only and no CMA or WES, so this criterion (no prior CMA/WES) is met.",Yes,"Policy lists relevant family history among features supporting WGS. The patient has an older sibling with severe intellectual disability (diagnosed by age 18), which is a relevant family history per the policy.",Not Specified,"The policy states genetic counseling is ""strongly recommended"" prior to WGS but does not make counseling an explicit coverage requirement; the record documents no pre-test counseling but counseling is not mandated as a coverage criterion.",81425,Applicable CPT for whole genome sequence analysis per the policy is 81425 (Genome; sequence analysis).,No,"Although the ordering provider and absence of prior CMA/WES meet policy requirements, the patient does not meet the policy's medical indication criteria for WGS (policy requires either multiple congenital anomalies or specified combinations of features; this infant has a single-organ congenital anomaly and family history but does not satisfy the required feature set, and policy directs targeted testing when a specific syndrome/test is suspected). Therefore WGS is not covered per the policy.",36931,3655,40586
Case3359,rag,all_correct,iter2,WES,Patient information states 'Whole exome sequencing (WES) is being requested to evaluate for an underlying genetic etiology.',Yes,"Policy criteria include features diagnosed by childhood (e.g., global developmental delay onset prior to 5 years, intellectual disability by 18). The patient is 4 years old with developmental concerns (meets age‑related presentation such as GDD onset <5 yrs). (Policy: definitions and WES criteria referencing GDD and pediatric onset.)",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient was referred by a developmental pediatrician, meeting the ordering‑provider requirement.",Yes,Policy requires clinical history suggesting a genetic cause plus specific features. The patient has significant hypotonia and ongoing developmental concerns (hypotonia and likely GDD) and a first‑degree relative (sibling) with developmental delay—meeting policy listed features for WES coverage (hypotonia; other first‑degree family member with similar features).,Not Specified,"Policy does not mandate prior testing (e.g., CMA) before WES except that targeted testing is preferred if a specific syndrome is suspected. Although the patient had a nondiagnostic CMA, no specific prior test is required by policy for WES.",Yes,Policy lists 'Other first‑ or second‑degree family member(s) with similar clinical features' as a relevant criterion. The patient has a sibling with developmental delay (first‑degree).,Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES but does not list counseling as a strict coverage requirement. The patient did receive pre‑test counseling, but counseling is not specified as a mandatory coverage criterion.",81415,Policy's applicable CPT codes list 81415 for exome sequence analysis (WES).,Yes,All policy coverage criteria for WES are met: ordered by a developmental pediatrician; clinical history suggests a genetic cause with qualifying features (hypotonia and affected sibling / developmental concerns consistent with GDD); presentation is nonspecific and prior CMA was nondiagnostic. Therefore per policy WES is proven and medically necessary.,36955,2477,39432
Case9978,rag,all_correct,iter2,WES,Patient information states the 53-year-old is undergoing whole exome sequencing (WES) ordered by the neurologist.,Not Specified,"The UnitedHealthcare WES policy does not impose an age limit for WES; eligibility criteria reference age of symptom onset (e.g., epileptic encephalopathy with onset before 3 years) but no patient age restriction is specified.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test is ordered by a neurologist (meets provider requirement).",Yes,"Policy lists 'epileptic encephalopathy with onset before three years of age' as an indication for WES; the patient had epileptic encephalopathy beginning before age three and persisting, so the medical indication is met.",Not Specified,The policy does not mandate specific prior tests for outpatient WES in this scenario (prior Fragile X was done but the policy does not require a specific prior test prior to WES for epileptic encephalopathy).,No,"Policy includes consanguinity or 'other first- or second-degree family member(s) with similar clinical features' as supportive criteria. The patient has a brother with an inborn error of metabolism but not described as having similar features, so the specified family-history criterion is not met.",Not Specified,The policy 'strongly recommends' genetic counseling prior to WES but does not state it as a strict coverage requirement; therefore counseling requirements are not explicitly specified as mandatory in the policy.,81415,Applicable CPT codes list 81415 for 'Exome; sequence analysis' (WES) in the policy's Applicable Codes section.,Yes,"Per the UnitedHealthcare policy, WES is medically necessary when ordered by an authorized specialist and the clinical history strongly suggests a genetic cause with 'epileptic encephalopathy with onset before three years of age' — all of which are met (ordered by neurologist; onset <3 years); thus coverage is supported.",36935,1678,38613
Case22,rag,all_correct,iter2,BRCA1/2,Patient information states he is undergoing BRCA1/2 testing to evaluate hereditary predisposition.,Yes,"Policy specifies testing in minors is investigational; patient is 18 (an adult) and policy criteria for prostate cancer apply 'at any age,' so age meets eligibility.",Not Specified,Policy requires testing be performed in a setting with suitably trained providers and genetic counseling but does not specify required ordering provider specialty; therefore provider-specific requirements are not specified.,Yes,Policy lists 'personal history of metastatic or intraductal/cribriform histology prostate cancer at any age' as medically necessary indication; patient has metastatic prostate cancer with intraductal/cribriform histology.,Not Specified,Policy does not mandate completion of any specific prior diagnostic genetic tests before BRCA1/2 germline testing in this clinical scenario.,Yes,"Policy includes family-history criteria (eg, close blood relative with metastatic or intraductal/cribriform prostate cancer); patient's father had metastatic intraductal/cribriform prostate cancer.",Yes,Policy requires appropriate pre- and post-test counseling in a setting with trained providers; patient completed pre-test counseling and will return for post-test follow-up with a genetic counselor.,Not Specified,"The provided policy text does not list or map specific CPT codes to BRCA1/2 testing, so a CPT code cannot be determined from the policy.",Yes,"Under the policy, germline BRCA1/2 testing is medically necessary for individuals with metastatic or intraductal/cribriform prostate cancer at any age; patient meets this criterion and counseling requirements, so test is covered.",18975,1859,20834
Case5605,rag,all_correct,iter2,WGS,Patient information states the 11-year-old was referred for whole genome sequencing (WGS).,No,"Policy allows rapid WGS only for critically ill infants in NICU/PICU; for non-rapid WGS 'whole genome sequencing is considered investigational in all other situations.' The patient is an 11-year-old who is not described as critically ill, so age/acuity eligibility is not met.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling; the patient had pre-test counseling completed with a genetic specialist, satisfying the clinician/counseling requirement.",No,"Policy specifies medically necessary indications for WES in children with unexplained congenital anomalies but restricts WGS to rapid use in critically ill infants; WGS for a non-critically ill 11-year-old is considered investigational, so the patient does not meet the policy's medical indication for WGS.",Yes,"Policy indicates prior genetic testing (eg, chromosomal microarray analysis) should be nondiagnostic before advanced sequencing; the record states a prior CMA was nondiagnostic.",No,"Policy lists specific family-history examples relevant to sequencing (eg, arrhythmia, BRUE in sibling, developmental delay, early sudden death); the patient’s family history (maternal aunt with pancreatic cancer) is not among the specified relevant family-history criteria.",Yes,"Policy requires genetic counseling by an experienced genetics provider; the patient had pre-test counseling with a genetic specialist, meeting the counseling requirement.",Not Specified,The provided BCBS_FEP policy text does not specify CPT/billing codes for WES or WGS.,No,"Under the policy, whole genome sequencing for diagnosis in non-critically ill children is considered investigational ('Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations'); therefore the requested WGS is not covered.",14822,2924,17746
Case19162,rag,all_correct,iter2,WGS,The patient information states the medical geneticist referred the neonate for whole genome sequencing (WGS).,Yes,"The policy specifies rapid WGS/WES eligibility for infants/neonates in the NICU/PICU; the patient is a neonate, so the age criterion (infant/neonate) is met. (Note: other non-age conditions also apply.)",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling; the patient was referred by a medical geneticist and pre-test counseling was completed with a genetic counselor, satisfying ordering/provider requirements.",Yes,"Policy medical indications include abnormal clinical features suggesting a genetic disease or complex metabolic phenotype and family history of an inborn error of metabolism; the neonate has complex neurologic abnormalities suggestive of a genetic/metabolic cause and a sibling with an inborn error of metabolism, meeting medical indication criteria.",No,"For standard WES/WGS policy expects prior genetic testing (eg, CMA and/or targeted testing) or failed prior testing; the record documents only nondiagnostic Fragile X testing and does not document prior CMA or other required prior genetic testing.",Yes,Policy lists family history of an inborn error of metabolism as a relevant criterion; the patient has a sibling with an inborn error of metabolism.,Yes,"Policy requires genetic counseling by an experienced individual; the patient had pre-test counseling with a genetic counselor and post-test follow-up is planned, meeting counseling requirements.",Not Specified,"The provided BCBS_FEP policy text does not specify CPT or billing codes for WGS/WES, so a specific CPT code cannot be selected from the policy document.",No,"The policy permits rapid WGS only for critically ill infants in the NICU/PICU meeting specified criteria. While the patient is a neonate with suggestive features and family history, there is no documentation the infant is critically ill or in NICU/PICU; the policy also states WGS is investigational for diagnosis in other situations. Therefore WGS as requested is not covered under the policy.",14852,44324,59176
Case15834,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) has been ordered.,Not Specified,"The policy includes age references for specific features (e.g., ID diagnosed by 18 years, onset criteria) but does not impose a general age exclusion or a single explicit age threshold that determines WES eligibility for this infant.",Not Answerable,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The provided clinical information notes a referral and pre-test counseling by a 'genetic specialist' but does not explicitly state who ordered the WES, so ordering-provider qualification cannot be confirmed.",No,"Policy coverage rationale requires either (A) one of specified major features (e.g., multiple congenital anomalies, global developmental delay, moderate–severe ID) OR (B) two or more listed features (one of which is autism spectrum disorder). The patient has suspected autism spectrum disorder only (and a family history of an aunt with a congenital anomaly), and there is no documented second qualifying feature or explicit statement that the clinical history 'strongly suggests a genetic cause.' Therefore the patient does not meet the defined medical indication.",Not Specified,"The policy does not specify mandatory prior testing for WES in a child being evaluated for ASD (prenatal WES does require prior CMA/karyotype). Although Fragile X testing was done and nondiagnostic, the policy does not require specific prior tests for this indication.",No,The policy lists 'other first- or second-degree family member(s) with similar clinical features' as a qualifying feature. The record documents a maternal aunt with a congenital anomaly but does not document that the aunt had clinical features similar to the infant's suspected ASD; therefore the patient does not meet the policy's family-history criterion as written.,Yes,"The policy 'strongly recommends' genetic counseling prior to WES/WGS. The patient had pre-test counseling completed with a genetic specialist, which meets the policy's counseling recommendation.",81415,WES corresponds to CPT code 81415 (Exome; sequence analysis) per the policy's Applicable Codes section.,No,"Under the policy WES is medically necessary only when defined clinical criteria are met (e.g., specific major features or ≥2 listed features including autism). The infant has only suspected ASD and no documented second qualifying feature or unequivocal 'clinical history strongly suggests a genetic cause.' Ordering-provider qualification is also not confirmed. Therefore coverage criteria are not met.",36936,3433,40369
Case13,rag,all_correct,iter2,WES,Patient was referred for whole exome sequencing (WES) after nondiagnostic karyotype (patient information explicitly states WES).,Yes,"The policy specifies WES may be medically necessary for children with unexplained congenital anomalies; the patient is a newborn with multiple congenital anomalies, so age criteria are met (policy: ""...evaluation of unexplained congenital or neurodevelopmental disorders in children"").",Not Answerable,"Policy requires the individual be evaluated by a clinician with expertise in clinical genetics and counseled. Patient info states pre-test genetic counseling was completed but does not explicitly identify the ordering/evaluating provider's specialty, so it cannot be confirmed whether the ordering provider meets the policy's stated provider requirement.",Yes,"Policy medical-necessity criteria require: (1) evaluation by a genetics-expert and counseling (patient has pre-test genetic counseling), (2) potential to change management, and (3) genetic etiology likely despite prior testing or prior testing failed to yield diagnosis. The newborn has multiple unexplained congenital anomalies, a family history of sibling with developmental regression, and prior karyotype was nondiagnostic, which aligns with the policy's indication for WES in children with unexplained congenital anomalies.",Yes,"Policy allows WES when previous genetic testing has failed to yield a diagnosis (examples include CMA and/or targeted testing). Patient had prior genetic testing (karyotype) that was nondiagnostic, satisfying the policy condition that prior testing failed to yield a diagnosis.",Yes,"Policy guidance lists family history of developmental delay as a relevant factor. Patient has a sibling with unexplained developmental regression, which is a relevant family history per the policy.",Yes,"Policy requires genetic counseling by an individual experienced in genetics. Patient information states pre-test genetic counseling was completed and post-test follow-up is planned, meeting the policy's counseling requirement.",81415,The requested test is whole exome sequencing; the CPT option in the list that best corresponds to clinical exome sequencing is 81415 (exome sequencing). The policy document does not list CPT codes explicitly.,Yes,"Based on the policy, WES is medically necessary for children with unexplained congenital anomalies when criteria are met. The patient is a newborn with multiple unexplained congenital anomalies, prior genetic testing was nondiagnostic, genetic counseling was completed, and there is relevant family history — collectively meeting the policy's coverage criteria.",14829,3092,17921
Case16487,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) has been ordered.,Not Specified,"The policy does not impose a general age cutoff for WES; age-based items in the criteria refer to specific features (e.g., ID diagnosed by 18 years, epileptic encephalopathy onset <3 years). The newborn age is not a disqualifying or explicitly required age in the policy.",No,"Policy requirement: 'WES is ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician.' The ordering provider is an oncologist, which is not one of the listed authorized specialties.",No,"Coverage requires the clinical presentation to strongly suggest a genetic cause plus specified features (e.g., multiple congenital anomalies, global developmental delay, persistent severe immunologic/hematologic disorder, or two+ listed features). The newborn’s presentation (recurrent BRUE) is not listed among those qualifying features and the clinical facts do not document the required feature set.",Not Specified,"The policy does not mandate specific prior tests for postnatal WES in this scenario (only that targeted testing be done first if a specific syndrome is suspected, and prenatal WES requires prior CMA/karyotype). The patient had nondiagnostic FISH, but the policy does not state FISH is a required prior test for WES.",Yes,"The policy lists 'other first- or second-degree family member(s) with similar clinical features' and family history/consanguinity among potential qualifying features. The patient has a maternal aunt with a persistent severe immunologic/hematologic disorder (a second-degree relative), so a relevant family history is present per policy definitions.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling a formal, mandatory coverage requirement. The patient did have pre-test counseling, which aligns with the recommendation, but counseling is not specified as a required criterion for coverage.",81415,"Policy applicable codes list CPT 81415 as 'Exome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' corresponding to WES.",No,"Per policy, WES coverage requires (among other things) ordering by an approved specialty and meeting specified clinical-feature criteria. Here the ordering provider is an oncologist (not an approved specialty) and the newborn’s presenting diagnosis (recurrent BRUE) does not meet the policy’s listed medical indications, so the request does not meet coverage criteria.",36947,2862,39809
Case3677,rag,all_correct,iter2,BRCA1/2,Patient is described as 'undergoing BRCA1/2 testing' for personal history of breast cancer and family history of pancreatic and other BRCA‑related cancers. (Patient info),Yes,"Policy states BRCA1/2 testing is medically necessary for individuals with personal history of breast cancer diagnosed at age 65 or younger; the patient is 46, meeting the age criterion. (Policy: Coverage Rationale)",Not Specified,Policy discusses need for providers familiar with hereditary cancer and recommends genetic counseling but does not specify a required ordering provider specialty/type. The order by a nurse practitioner is documented but no explicit ordering-provider restriction is given. (Policy: Description of Services; Coverage Rationale),Yes,Patient has a personal history of breast cancer and a family history that includes a first‑degree relative with pancreatic cancer and multiple affected relatives on the same side — meeting listed BRCA1/2 and multi‑gene testing criteria. (Policy: Coverage Rationale & Definitions of BRCA‑Related Cancers and family criteria),Not Specified,Policy does not require completion of specific prior tests before BRCA1/2 single gene testing; prior CMA was nondiagnostic but policy does not list CMA as required. (Policy: Coverage Rationale),Yes,Policy lists family history (first‑ or second‑degree relative with pancreatic cancer and multiple affected relatives on same side) as relevant criteria; patient has a mother with pancreatic cancer and at least two additional maternal relatives. (Policy: Coverage Rationale; Definitions),Yes,"Policy strongly recommends pre‑test genetic counseling; the patient completed pre‑test genetic counseling and plans post‑test follow‑up, meeting counseling expectations. (Policy: Coverage Rationale)",81162,"Policy lists CPT 81162 for BRCA1/BRCA2 full sequence analysis plus full duplication/deletion analysis, which corresponds to standard BRCA1/2 testing. (Policy: Applicable Codes)",Yes,"Patient meets age, personal history, and family history criteria for BRCA1/2 testing per policy; counseling completed; no ordering‑provider restriction specified — therefore BRCA1/2 testing is covered. (Policy: Coverage Rationale; Definitions; patient facts)",38638,1714,40352
Case3474,rag,all_correct,iter2,WGS,Patient info explicitly states whole genome sequencing (WGS) is being ordered.,Not Specified,"The policy does not impose a general age cutoff for WGS; age-qualifiers exist for certain features (e.g., ID by 18, GDD onset <5) but no overall age-based exclusion for WGS is specified.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient’s test is ordered by a medical geneticist (meets requirement).",Yes,"Policy medical-necessity for WGS requires: neither CMA nor WES performed, ordered by an approved specialist, and clinical history suggesting genetic cause with either one of certain major features or two or more listed features. The patient has no CMA/WES documented, is ordered by a medical geneticist, and has a congenital anomaly (choanal atresia) plus a first‑degree relative with developmental delay (meets the 'two or more' features branch).",Yes,"Policy criterion for WGS states 'Neither CMA nor WES have been performed.' Patient history notes only a prior karyotype (nondiagnostic) and no CMA or WES, so the prior-test requirement is satisfied.",Yes,"Policy lists 'Other first- or second-degree family member(s) with similar clinical features' as an eligibility feature; patient has an older sibling with developmental delay, which is relevant per policy.",Yes,"Policy 'strongly recommends' genetic counseling prior to WGS/WES. Patient completed pre-test genetic counseling multiple times with planned post-test follow-up, meeting the counseling expectation in the policy.",81425,"Policy's applicable CPT codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to WGS.",Yes,"Under the UnitedHealthcare WGS policy WGS is medically necessary when criteria are met: ordered by an approved specialist (medical geneticist), neither CMA nor WES performed, and clinical history suggests a genetic cause with qualifying features. The patient satisfies these (congenital anomaly + affected sibling), so WGS is covered per policy.",36944,2284,39228
Case15938,rag,all_correct,iter2,WGS,Patient info states whole-genome sequencing (WGS) is being considered; the request is explicitly for WGS.,Not Specified,"The policy does not impose a specific minimum/maximum age that would exclude a one-week-old; age-based cutoffs in the policy apply to specific phenotypes (e.g., ID diagnosed by 18 years, seizure onset <3 years) but no blanket age exclusion for WGS is specified.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neonatologist, which meets the requirement.",No,"Policy coverage for WGS requires (among other things) that the clinical history strongly suggests a genetic cause plus either (A) one of the major features (multiple congenital anomalies, moderate/severe ID by 18, global developmental delay, epileptic encephalopathy) OR (B) two or more of the listed secondary features (e.g., laboratory abnormalities suggestive of an IEM, hypotonia, unexplained developmental regression, family members with similar features, etc.). The patient has a laboratory abnormality suggestive of an IEM (conjugated hyperbilirubinemia) but does not have a second qualifying feature in the proband (the sibling's developmental regression is not the same clinical feature as the infant), so the medical-indication criteria are not met.",Yes,"Policy requires for WGS that neither CMA nor WES have been performed. Patient had a nondiagnostic karyotype but no CMA or WES, so this prior-test condition is satisfied.",No,"The policy lists family history (other first- or second-degree members with similar clinical features) as a qualifying feature. The patient has a sibling with unexplained developmental regression, but that is not a family member with 'similar clinical features' to the infant's presentation (neonatal cholestasis/IEM concern), so the family-history criterion relevant to eligibility is not met.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not state a documented pretest genetic counseling requirement as a strict coverage prerequisite; the patient has no documented pretest counseling, but counseling is not specified as mandatory for coverage in the policy.",81425,"Policy applicable codes list 81425 = Genome (sequence analysis) for unexplained constitutional/heritable disorder, which corresponds to clinical WGS.",No,"Although the ordering provider (neonatologist) and the prior-test condition (no CMA/WES performed) meet policy requirements, the patient does not meet the medical-indication criteria per the policy (only one secondary feature — lab abnormality suggestive of an IEM — without a second qualifying feature or a listed major feature). Therefore coverage is not supported under the policy.",36949,3630,40579
Case4067,rag,all_correct,iter2,WES,Patient narrative explicitly states 'whole exome sequencing (WES) has been ordered.',Not Specified,"The policy does not impose a strict single age cutoff for outpatient WES; criteria reference features diagnosed by certain ages (e.g., ID by 18, global developmental delay onset <5) but there is no absolute age exclusion and the patient (age 5) falls within pediatric range—policy therefore provides no explicit age-based disqualification.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a developmental pediatrician, which meets the policy requirement.",No,"Policy coverage requires specific clinical indications (e.g., global developmental delay, ID by 18, or two-or-more listed features). The record documents significant hypotonia only (hypotonia appears in the policy's 'two-or-more' list) with no additional qualifying features (no documented global developmental delay, ID, multiple congenital anomalies, etc.), so the patient does not meet the defined medical indication.",Not Specified,"The policy does not mandate a specific prior test for outpatient WES in this scenario (it only advises targeted testing if a specific syndrome is suspected, and prenatal WES has CMA/karyotype requirements). The patient had nondiagnostic karyotype, but no specific prior-test requirement is defined for this indication.",Yes,"The policy lists family history (other first- or second-degree family members with similar clinical features) as a relevant criterion. The patient has a notable family history (paternal uncle with sudden unexplained death before 35) raising concern for a heritable disorder, which is a relevant family-history fact per the policy.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not make counseling a strict coverage prerequisite; the patient record does not document counseling, and the policy therefore does not specify counseling as a mandatory eligibility criterion.",81415,"Policy's applicable CPT list shows 81415 is the code for 'Exome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' — corresponding to the ordered proband WES.",No,"Although the ordering provider meets policy requirements and a concerning family history and prior karyotype nondiagnostic exist, the policy requires specific clinical features (e.g., global developmental delay, ID by 18, or two or more listed features). The documentation shows only hypotonia without additional qualifying features, so the medical necessity criteria in the policy are not met and WES is not covered per the policy.",36932,2816,39748
Case11514,rag,all_correct,iter2,WES,Patient info: 'whole exome sequencing (WES) has been requested' — the requested test is explicitly WES.,Yes,"Policy includes age-referenced criteria (e.g., features diagnosed by 18 years of age). The patient is 10 years old, which meets those age-based thresholds in the policy.",No,"Policy requirement: 'WES is ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician.' The ordering provider is an oncologist, which does not meet the specified provider requirement.",No,"Policy requires clinical history strongly suggesting a genetic cause plus either one primary feature (e.g., multiple congenital anomalies, moderate/severe ID by 18) or two or more secondary features (e.g., laboratory abnormalities suggestive of an IEM plus another listed feature). The patient has conjugated hyperbilirubinemia (a lab abnormality suggestive of IEM) and family history of a cousin with an IEM, but lacks a primary feature or a second qualifying secondary feature per the policy; cousin is not a first/second-degree relative listed in the policy.",Not Specified,"Policy does not mandate specific prior testing before outpatient WES (prenatal WES has CMA/karyotype requirements). Although CMA was previously performed and nondiagnostic, the policy does not require prior tests for WES in this non-prenatal setting.",No,"Policy specifies family-history criteria (other first- or second-degree family members with similar features, consanguinity). The patient has a cousin with an IEM (third-degree), which does not meet the policy's specified first- or second-degree family history requirement.",Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WES but does not list pre-test counseling as a mandatory coverage criterion. No pre-test counseling is documented for this patient.,81415,Policy's Applicable Codes list maps WES (exome sequence analysis) to CPT code 81415 ('Exome ... sequence analysis').,No,"Coverage denial is supported by policy: WES requires (1) ordering by specified provider types (medical geneticist, neonatologist, neurologist, or developmental pediatrician) — not met (oncologist ordered), and (2) meeting defined clinical criteria (either a primary feature or two or more secondary features) — patient only has one secondary feature per policy. Therefore the request does not meet the policy's coverage criteria.",36969,2850,39819
Case11981,rag,all_correct,iter2,WGS,Patient information explicitly states 'Whole genome sequencing (WGS) is being requested.' Basis: patient clinical note.,Yes,"Policy includes age-related features (e.g., 'hypotonia or hypertonia in infancy', conditions diagnosed by 18 years). Patient is 9 years old and had abnormal muscle tone noted in infancy, meeting the age-related feature 'hypotonia or hypertonia in infancy.' Basis: UnitedHealthcare WGS criteria and patient facts.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. Patient was referred by neurology and had pre-test discussion with a genetic specialist, satisfying the ordering-provider requirement per policy. Basis: UnitedHealthcare WGS ordering-provider list and patient facts.",No,"Policy requires either one of the first set of features (e.g., global developmental delay, ID by 18) OR two or more features from the second list (e.g., hypotonia in infancy plus another). Patient has abnormal muscle tone in infancy (one qualifying second-list feature) and ongoing motor concerns, but no clear second qualifying feature documented (no documented global DD/ID, epilepsy, multisystem congenital anomalies, etc.). Therefore the documented clinical facts do not meet the policy's defined medical indication for WGS. Basis: UnitedHealthcare WGS clinical criteria and patient facts.",Yes,"Policy for WGS requires that 'Neither CMA nor WES have been performed.' Patient history documents only fragile X testing (nondiagnostic) and does not report prior CMA or WES, consistent with that WGS prerequisite. Basis: UnitedHealthcare WGS prerequisite and patient facts.",No,"Policy specifies family-history features such as 'other first- or second-degree family member(s) with similar clinical features' or consanguinity. Patient has a maternal uncle with a severe immunologic disorder (second-degree), but this is not documented as 'similar clinical features' to the proband's motor/developmental findings. Thus the documented family history does not meet the policy's specified family-history eligibility criteria. Basis: UnitedHealthcare criteria and patient facts.",Not Specified,"Policy states genetic counseling is 'strongly recommended prior to WES or WGS' but does not state it as a strict coverage requirement. Patient had pre-test discussion with a genetic specialist, but counseling is recommended (not a mandatory coverage criterion) per policy. Basis: UnitedHealthcare counseling language and patient facts.",81425,"Policy's applicable CPT codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to clinical WGS. Basis: UnitedHealthcare Applicable Codes table.",No,"Although ordering-provider and age-related items are satisfied and no prior CMA/WES is documented, the policy requires specific clinical indications (either one of the primary features or two or more secondary features). The patient only documents hypotonia/abnormal muscle tone in infancy (one secondary feature) and lacks a second clearly documented qualifying feature; therefore the patient does not meet the policy's medical necessity criteria for WGS. Basis: UnitedHealthcare WGS coverage criteria and patient facts.",36954,4206,41160
Case7682,rag,all_correct,iter2,WES,Patient record explicitly states whole exome sequencing (WES) is being requested.,Yes,"Policy criteria reference pediatric indications (e.g., features diagnosed by age 18). The patient is 9 years old, which meets the age-related criteria (under 18) cited in the WES policy.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is a developmental pediatrician, which satisfies the requirement.",Yes,"Policy lists 'multiple congenital anomalies (must affect different organ systems)' and 'other first- or second-degree family member(s) with similar clinical features' as qualifying features. The patient has multiple congenital anomalies affecting different organ systems and a sibling with developmental delay, meeting the clinical indications.",Not Specified,"The policy does not mandate specific prior tests for postnatal WES. The record notes a nondiagnostic karyotype, but the policy does not require prior CMA/karyotype as a universal prerequisite for WES in this non‑prenatal setting.",Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' and 'consanguinity' as relevant family-history criteria. The patient has a sibling with developmental delay, which is relevant under the policy.",Yes,"Policy states genetic counseling is strongly recommended prior to WES; the record documents pre-test counseling with a genetic specialist and plans for post-test follow-up, meeting the counseling recommendation.",81415,Policy applicable CPT codes list 81415 for exome sequence analysis (proband). WES corresponds to CPT 81415 (with comparator codes listed separately if parent/sibling exomes are submitted).,Yes,"All policy coverage criteria are met: WES is ordered by an allowed specialist (developmental pediatrician), the patient has multiple congenital anomalies affecting different organ systems and a relevant affected sibling (policy qualifying features), pre-test genetic counseling was performed, and the request is for diagnostic evaluation. Therefore WES is medically necessary per the UnitedHealthcare WES coverage rationale.",36935,2069,39004
Case3494,rag,all_correct,iter2,WES,Patient information explicitly states 'whole exome sequencing (WES) is being requested.',Yes,"Cigna policy requires the member be <21 years of age for ES; the patient is a six‑week‑old infant, which meets this age criterion (policy: 'Member is <21 years of age').",Not Specified,"The policy requires an 'appropriate genetic and family history evaluation' and the rendering laboratory be qualified, but it does not specify explicit ordering‑provider specialty/credential requirements for ordering ES.",No,"Cigna's ES criteria require that a genetic etiology is most likely based on specified phenotype pathways (e.g., multiple congenital anomalies, or TWO listed criteria such as a major abnormality plus symptoms of a complex neurodevelopmental disorder) and accompanying documentation. The infant has a single congenital abnormality and only a concern for evolving neurodevelopmental disorder; the required clinical documentation/detailed evaluation letter is not provided, so the defined medical indication criteria are not met.",No,"The guideline requires documentation of prior genetic/family evaluation and previous tests performed/results as part of the clinical letter. The patient has had no prior genetic testing and no such documentation was provided, so required prior testing/documentation has not been completed.",Not Specified,"The policy requires that family history be included in the clinical evaluation, but family history is not defined as a standalone eligibility criterion for postnatal ES (except specific prenatal scenarios). While the patient has a sibling with dysmorphic features, the policy does not explicitly state family history/consanguinity alone makes the patient eligible.",Not Specified,"The policy and cited ACMG guidance recommend pretest counseling by a geneticist/genetic counselor and formal consent, but the Cigna ES coverage criteria do not explicitly make documented genetic counseling a separate required element for coverage; the family declined counseling, and the policy does not state this alone denies coverage.",81415,Cigna billing section specifies 81415 should be billed for the proband when analyzing the entire exome sequence ('81415 should be billed for the proband').,No,"Coverage requires ALL listed ES criteria be met (no prior ES/WGS, required clinical/family evaluation with a detailed clinical letter, <21 y, genetic etiology most likely per listed phenotype criteria, alternate etiologies considered, presentation not fitting a syndrome with available first‑tier testing, predicted impact on care, etc.). Although age and absence of prior ES/WGS are met, the required detailed clinical evaluation/documentation is not provided and the phenotype criteria (per policy) are not clearly met. Therefore the test does not meet Cigna's all‑criteria medical necessity requirements and is not covered.",10475,3024,13499
Case7014,rag,all_correct,iter2,WGS,Patient info explicitly states whole genome sequencing (WGS) is being requested.,Not Specified,The policy's WGS coverage criteria do not set an age exclusion/limit for outpatient WGS; age-based limits are not specified as a barrier for this indication.,Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the request was made by neurology (neurologist), meeting the provider requirement.",Yes,"Policy requires nonspecific presentation and one of specified features. The infant has nonspecific multiple congenital anomalies and a second-degree relative (maternal aunt) with a congenital anomaly, meeting the clinical indication list in the policy.",Yes,"Policy requires that neither CMA nor WES have been performed prior to WGS. Patient had a nondiagnostic karyotype; there is no record of CMA or WES, so the policy condition (no prior CMA/WES) is satisfied.",Yes,Policy lists 'other first- or second-degree family member(s) with similar clinical features' as an indicator; patient has a maternal aunt with a congenital anomaly (a second-degree relative).,Yes,"Policy 'strongly recommends' genetic counseling prior to WGS; patient completed pre-test genetic counseling with a genetic specialist, meeting the counseling recommendation.",81425,"Policy's applicable CPT codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' which corresponds to WGS.",Yes,"Per the UnitedHealthcare policy, WGS is medically necessary when results are expected to influence management and all listed criteria are met. The infant has a nonspecific phenotype (multiple congenital anomalies), a relevant family history (maternal aunt), ordering provider is a neurologist, neither CMA nor WES were performed, and pre-test genetic counseling was completed; results will be reviewed with the neurology team and family. These facts satisfy the policy coverage criteria for WGS.",36945,3520,40465
Case13517,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) was ordered.,Not Specified,"The policy does not impose an overall age cutoff for WES; age limits in the policy apply to specific clinical features (e.g., ID or sensory impairment diagnosed by age 18). The patient is 16 but no overall age-based exclusion or requirement for WES is specified in the policy.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The test was ordered by a developmental pediatrician (patient fact), meeting the policy provider requirement.",Yes,"Policy allows WES when clinical history suggests a genetic cause and one feature is present, including 'laboratory abnormalities suggestive of an inborn error of metabolism (IEM)'. The patient has conjugated hyperbilirubinemia with a sibling having lab abnormalities suggestive of an IEM, satisfying the listed clinical indication.",Not Specified,The policy does not define specific prior diagnostic tests required for non‑prenatal WES in this scenario (except that targeted single‑gene/panel testing is preferred if a specific syndrome is suspected). No mandatory prior tests are specified for evaluation of suspected IEM in the policy.,Yes,"Policy lists 'Other first- or second-degree family member(s) with similar clinical features' as a qualifying feature for WES. The patient has a sibling with laboratory abnormalities suggestive of an IEM, meeting this family-history criterion.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES but does not state counseling as a mandatory coverage criterion. Patient facts note pre-test counseling was completed, but the policy does not make this a required coverage element.",81415,Policy applicable codes list 81415 for exome sequence analysis (proband). The requested WES for the patient corresponds to CPT code 81415.,Yes,"Per policy coverage rationale, WES is medically necessary when (1) clinical presentation is nonspecific, (2) ordered by an approved specialist, and (3) one qualifying feature is present (e.g., laboratory abnormalities suggestive of IEM or a first-degree relative with similar features). The patient: has nonspecific conjugated hyperbilirubinemia, was ordered by a developmental pediatrician, and has a sibling with lab findings suggestive of an IEM. These facts meet the policy criteria for covered WES.",36953,2014,38967
Case14127,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued to investigate an underlying genetic etiology.,Yes,"Policy lists Global Developmental Delay and Intellectual Disability diagnosed by 18 years as qualifying features for WES. Patient is 17 with lifelong global developmental delay, meeting the age-related criteria in the policy.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The medical geneticist is coordinating the testing per the patient information.",Yes,"Policy defines Global Developmental Delay as an explicit indication for WES. The patient has GDD and a family history of early-onset epileptic encephalopathy (also listed in policy), so they meet the clinical indication(s).",Not Specified,"The policy does not mandate prior testing (e.g., CMA) before WES for this outpatient diagnostic scenario; it only directs targeted testing if a specific syndrome is suspected. Patient had nondiagnostic FISH, but the policy does not specify required prior tests for WES in this context.",Yes,"Policy lists other first- or second-degree family members with similar clinical features and consanguinity as relevant features. Patient has a sibling with epileptic encephalopathy with onset before three years, which is relevant per policy.",Not Specified,The policy 'strongly recommends' genetic counseling prior to WES but does not state it as a mandatory coverage requirement. Patient received pre-test counseling and plans post-test counseling; counseling is noted but the policy does not require it as a strict coverage criterion.,81415,"Policy's applicable CPT codes list 81415 for Exome (sequence analysis), which corresponds to WES.",Yes,"Per the UnitedHealthcare policy, WES is proven and medically necessary when specified criteria are met: ordered by an approved specialist (medical geneticist), and the proband has Global Developmental Delay (a listed qualifying feature). Patient is 17, has GDD, has relevant family history, prior FISH nondiagnostic, and testing is coordinated by a medical geneticist with genetic counseling—therefore coverage criteria in the policy are satisfied.",36965,2403,39368
Case15820,rag,all_correct,iter2,CMA,Patient information states chromosomal microarray (CMA) has been ordered; policy addresses CMA for developmental disorders.,Yes,"Policy requires testing to be performed on a living child or adult; patient is a 31-year-old adult, meeting this age-related criterion.",Not Specified,"Policy requires pre- and post-test genetic counseling and that the rendering laboratory be qualified, but it does not specify required ordering provider specialty or type for CMA.",Yes,"Policy lists developmental delay/intellectual disability as an accepted presentation; patient has DD/ID, no prior CMA, and diagnosis not made clinically alone, meeting the diagnostic criteria.",Yes,"Policy requires no previous CMA testing as a condition; patient has no prior genetic testing reported, satisfying the prior-test requirement.",No,"Policy only excludes CMA for family history of chromosome rearrangement in phenotypically normal individuals; patient has maternal early breast cancer (not a chromosome rearrangement), so relevant family-history exclusion is not present.",Yes,"Policy requires pre- and post-test genetic counseling; patient completed multiple pre-test counseling sessions with a genetic counselor and plans post-test follow-up, satisfying counseling requirements.",81228,Policy lists CPT 81228 for constitutional chromosomal microarray (array CGH); this corresponds to the requested CMA.,Yes,"Patient meets policy coverage criteria: living adult with unexplained DD/ID, no prior CMA, appropriate pre-test counseling, and no exclusionary family history; therefore CMA is covered per the guideline.",10097,1435,11532
Case13675,rag,all_correct,iter2,WGS,Patient note explicitly states whole genome sequencing (WGS) is being pursued.,Yes,"Policy includes age-based items (e.g., features diagnosed by age 18) and the patient is an 8‑week‑old infant with congenital hearing/visual impairment (meets the 'diagnosed by 18 years' age criterion).",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the order/referral is from a neonatologist.",No,"Policy medical-necessity criteria for WGS require (in part) either a major feature (e.g., multiple congenital anomalies, global developmental delay, etc.) OR two or more listed features (one of which is 'significant hearing or visual impairment'). The patient has significant congenital hearing and/or visual impairment only (one listed feature) and no documentation of an additional qualifying feature or a major listed feature, so the defined clinical criteria are not met.",Yes,"Policy for WGS states 'Neither CMA nor WES have been performed' as a criterion. Patient had prior FISH (nondiagnostic) but no CMA or WES documented, so this criterion is satisfied.",No,"The policy specifies relevant family-history criteria (e.g., other first/second‑degree family members with similar clinical features or consanguinity). The documented family history (father with long QT syndrome) is not one of the policy-defined family-history items relevant to WGS eligibility.",Not Specified,Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make pre-test counseling an explicit coverage prerequisite; the record documents no pre-test counseling but the policy does not specify it as a required coverage criterion.,81425,"Policy's applicable CPT codes list 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' which corresponds to WGS.",No,"Although ordering provider, age, and prior-test status meet policy requirements, the patient does not meet the policy's defined clinical indication for WGS (patient has only one listed feature—significant hearing/visual impairment—where the policy requires either a major feature or two or more listed features). Therefore coverage criteria are not fully met.",36956,3582,40538
Case2162,rag,all_correct,iter2,WGS,Patient information explicitly states the infant was referred for whole genome sequencing (WGS).,Not Specified,The policy refers to 'infants' and 'children' but provides no numeric age cutoffs; age-related eligibility is not explicitly specified in the policy text.,No,"Policy Criterion 1 requires evaluation by a clinician with expertise in clinical genetics (including family history and phenotype) and counseling. The ordering/referring provider is a general practitioner, not documented as a genetics clinician, so the policy's provider requirement is not met.",Yes,"The policy defines unexplained multiple congenital anomalies as a clinical indication for exome/genome sequencing. The infant has multiple congenital anomalies identified at birth, meeting a defined medical indication in the policy.",No,"Policy criteria for standard testing expect previous genetic testing (eg, chromosomal microarray and/or targeted single-gene testing) or prior testing having failed to yield a diagnosis. The record shows only nondiagnostic Fragile X testing and no documentation of CMA or other targeted testing, so required prior testing has not been completed per policy.",Yes,"The policy lists relevant family history items (eg, developmental delay) as pertinent for consideration. The patient has an older sibling with autism spectrum disorder (a neurodevelopmental condition), which is relevant under the policy's family-history considerations.",Yes,"The policy requires genetic counseling as part of evaluation by a genetics clinician. The patient record states pre-test genetic counseling has been completed with plans for post-test follow-up, meeting the policy's counseling requirement.",81425,"Among the provided CPT options, 81425 corresponds to whole genome sequencing, which matches the requested test (WGS).",No,"Per the policy, whole genome sequencing is medically necessary only as rapid WGS for critically ill infants in the NICU/PICU meeting specified criteria. For non-critically ill children or other situations WGS is considered investigational. This infant is not documented as critically ill or in NICU/PICU and thus WGS is investigational and not covered under the policy.",14818,4175,18993
Case7376,rag,all_correct,iter2,WES,Patient clinical info states whole exome sequencing (WES) has been ordered.,No,"Policy includes age-specific criteria for some qualifying features (e.g., intellectual disability or sensory impairment diagnosed by age 18). The member is 73 with no documentation of meeting those age-dependent criteria, so age-based eligibility in the policy is not met.",Yes,"Policy requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering/referring provider is a neurologist, meeting the requirement.",No,"Policy requires clinical presentation nonspecific + one of specified high‑priority features or two or more listed features (many pediatric/early‑onset items, family members with similar features, consanguinity, etc.). The record documents an unexplained major abnormality of ≥1 organ system but lacks the specific qualifying features listed in the policy, so medical indication per policy is not met.",Not Specified,Policy does not mandate specific prior tests for outpatient WES in non‑prenatal settings (other than performing targeted testing first if a specific syndrome is suspected); prior FISH was nondiagnostic but the policy does not list FISH/CMA/karyotype as a required prior test for the described adult outpatient indication.,No,"Policy lists family history of other first- or second-degree relatives with similar clinical features or consanguinity as qualifying. The patient’s family history (sister with triple‑negative breast cancer) is not documentation of a relative with similar features to the proband nor consanguinity, so it does not meet the policy’s family‑history criteria.",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS. The record documents pre-test counseling was completed with a genetic specialist, meeting the counseling expectation in the policy.",81415,Applicable codes in the policy list 81415 for exome (sequence analysis); this is the CPT code corresponding to WES.,No,"Although ordering provider specialty and pre-test counseling meet policy expectations and the requested test is WES (CPT 81415), the policy requires specific clinical features (e.g., early‑onset developmental/neurologic criteria, multisystem congenital anomalies, family members with similar features, consanguinity, etc.) for WES to be medically necessary. The patient record does not document any of those qualifying features; therefore per the UnitedHealthcare WES/WGS policy the test is not covered.",36945,2720,39665
Case11124,rag,all_correct,iter2,WES,Patient information explicitly states whole-exome sequencing (WES) has been ordered.,Yes,"Policy lists age-related criteria (e.g., global developmental delay with onset prior to 5 years and features diagnosable by age 18). The patient is an infant with developmental delay (onset <5 years), meeting the policy's age-related criteria for WES.",No,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider here is an oncologist, which does not meet the policy ordering-provider requirement.",Yes,"Policy indicates WES is medically necessary when clinical history strongly suggests a genetic cause and one qualifying feature (e.g., global developmental delay) is present. The infant presents with developmental delay, consistent with the listed indication.",Not Specified,Policy does not mandate a specific prior test for postnatal WES (other than targeted testing if a specific syndrome is suspected). Prior FISH was nondiagnostic but the policy does not require particular prior testing in this scenario.,Yes,"Policy lists 'other first- or second-degree family member(s) with similar clinical features' and consanguinity as relevant criteria. The family history includes an affected older sibling (childhood hearing impairment), which the clinical documentation identifies as supporting hereditary evaluation.",Yes,"Policy states genetic counseling is strongly recommended prior to WES/WGS. Patient record documents pre-test counseling was completed and post-test counseling planned, satisfying the counseling recommendation in the policy.",81415,Policy lists CPT 81415 for exome (sequence analysis) for unexplained constitutional/heritable disorders; this corresponds to the ordered WES for the proband.,No,"Although the patient meets clinical and age indications and counseling was done, the policy explicitly requires WES to be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is an oncologist, so the policy's ordering-provider requirement is not met and the test is not covered per the policy.",36940,2446,39386
Case8051,rag,all_correct,iter2,WES,Patient info states whole exome sequencing (WES) is being ordered to evaluate the infant's congenital cardiac anomaly.,Not Specified,"The policy references children/infants and includes guidance (ACMG note) about testing prior to 1 year, but the policy does not set a strict age cut‑off for standard WES; no explicit age-based exclusion is specified.",No,Policy criterion #1 requires evaluation by a clinician with expertise in clinical genetics (including counseling). The ordering provider is a family medicine physician and there is no documentation that a clinician with genetics expertise evaluated the infant; therefore provider requirements are not met per policy.,Yes,"Policy permits WES for unexplained congenital anomalies in children. The infant has a major congenital cardiac anomaly and testing is being pursued to clarify a genetic/syndromic etiology, which matches the policy's medical indication.",Yes,"Policy allows WES when previous genetic testing has failed to yield a diagnosis. The patient had prior FISH testing that was nondiagnostic, satisfying the 'previous testing failed' criterion.",No,"The policy specifies certain family history items relevant to eligibility (eg, arrhythmia, developmental delay, inborn errors, LQTS, sudden unexplained death). The only family history noted is maternal short stature, which is not among the policy's specified family-history items.",Not Answerable,"Policy requires genetic counseling by an individual with experience/expertise in genetic medicine and documentation of evaluation by a genetics clinician. The record states pre-test counseling was completed but does not document the counselor's qualifications or that the genetics-clinician evaluation occurred, so adequacy cannot be confirmed from provided information.",81415,"The requested test is whole exome sequencing (WES); of the CPT options provided, 81415 corresponds to exome sequencing.",No,"Although the infant meets the medical indication for WES and prior testing was nondiagnostic, the policy requires documentation of evaluation by a clinician with expertise in clinical genetics (including counseling). That documentation/provider qualification is not present in the patient info (ordering provider is a family medicine physician), so not all required policy criteria are met and the test is not covered per the policy.",14840,2666,17506
Case19905,rag,all_correct,iter2,WES,Patient is a 3-year-old being considered for whole exome sequencing (WES) per the clinical information.,Not Specified,"The policy does not impose an overall age limit for WES for multiple congenital anomalies; age-based limits in the policy apply to specific features (e.g., ID diagnosed by 18 years) but are not a restricting criterion for this patient.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a developmental pediatrician (meets requirement).",Yes,Policy lists 'multiple congenital anomalies (must affect different organ systems)' as a qualifying clinical feature for WES; the patient is described with multiple congenital anomalies and thus meets a defined medical indication.,Not Specified,"The policy does not require specific prior tests for postnatal WES in this scenario; prenatal WES has prior CMA/karyotype requirements, but postnatal WES prior-test requirements are not defined.",No,"Policy includes family members with similar clinical features or consanguinity as qualifying features; the documented family history is a mother with long QT (not similar features to the proband's multiple congenital anomalies), so the patient does not meet the policy's family-history criterion.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES but does not state counseling is a required coverage criterion; the patient has no counseling to date, but counseling is not mandated as a coverage prerequisite in the policy.",81415,CPT code 81415 corresponds to exome (sequence analysis) and is listed in the policy as the exome code.,Yes,"Per the UnitedHealthcare WES policy, WES is medically necessary when ordered by an approved provider and the patient has qualifying features. The patient is a 3-year-old referred by a developmental pediatrician (approved ordering provider) with multiple congenital anomalies and prior nondiagnostic karyotype — meeting the policy's clinical indication for WES; genetic counseling is recommended but not required for coverage.",36917,2386,39303
Case10850,rag,all_correct,iter2,WGS,Patient information states whole genome sequencing (WGS) has been ordered.,Not Specified,"The policy does not impose a specific age cutoff for WGS; while definitions mention onset ages for some features (e.g., GDD onset <5 years), the policy’s WGS criteria do not state an age-based exclusion that would rule out a 13‑year‑old.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a developmental pediatrician, meeting this requirement.",Yes,"Policy lists Global Developmental Delay as an explicit clinical indication for WGS; the patient has global developmental delay, meeting that criterion.",Yes,"Policy criterion for WGS states neither CMA nor WES have been performed. The patient had FISH (nondiagnostic) and no CMA or WES, so the prior-test condition for WGS is satisfied.",Yes,"Policy enumerates family history (other first- or second-degree family members with similar features) and dysmorphic features as relevant; the patient has an aunt with dysmorphic features (a second-degree relative), which is relevant per policy.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WGS but does not make counseling a required coverage criterion. The patient did receive pre-test counseling, which meets the recommendation.",81425,"Policy’s applicable CPT codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' which corresponds to WGS.",Yes,"Per the policy, WGS is medically necessary when (a) ordered by an appropriate provider (developmental pediatrician), (b) clinical presentation includes listed features (global developmental delay), and (c) neither CMA nor WES have been performed. The patient meets these criteria, has relevant family history, and completed pre-test counseling; therefore coverage criteria are met.",36937,3262,40199
Case19321,rag,all_correct,iter2,WES,Patient information states 'whole exome sequencing (WES) is being pursued.',Yes,"Policy includes pediatric neurodevelopmental indications (e.g., global developmental delay, autism spectrum disorder, ID diagnosed by age 18). Patient is 1 year old with neurodevelopmental disorder/concern for ASD, meeting age-related pediatric criteria (policy: features with onset prior to 5/18 years as applicable).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The patient was referred by a neurologist, meeting this requirement.",Yes,"Policy states WES is medically necessary when clinical history strongly suggests a genetic cause and features such as autism spectrum disorder or family members with similar features are present. Patient has a complex neurodevelopmental disorder concerning for ASD and a second‑degree relative (maternal aunt) with congenital anomalies, satisfying the listed clinical indications.",Not Specified,"The WES coverage criteria do not mandate completion of specific prior tests (CMA is not required prior to WES in the policy). Patient did have prior CMA nondiagnostic, but policy does not explicitly require prior testing before WES.",Yes,"Policy lists 'other first‑ or second‑degree family member(s) with similar clinical features' as a feature supporting WES. The patient has a maternal aunt (second‑degree relative) with multiple congenital anomalies, which is relevant per the policy.",Yes,"Policy 'strongly recommends' genetic counseling prior to WES/WGS. Patient completed pre‑test genetic counseling and has plans for post‑test follow up, meeting the counseling expectation in the policy.",81415,Policy applicable CPT codes list 81415 for exome (sequence analysis); this best corresponds to WES requested.,Yes,"Under the UnitedHealthcare WES policy WES is medically necessary when ordered by an approved specialist and the clinical history suggests a genetic cause with supporting features (e.g., ASD/global developmental issues and relevant family history). The patient is a 1‑year‑old with neurodevelopmental disorder concerning for ASD, has a relevant second‑degree family history, the test is ordered by a neurologist, pretest counseling was completed, and prior CMA was nondiagnostic — therefore criteria for coverage are met.",36944,2754,39698
Case2496,rag,all_correct,iter2,WES,Patient information states a prenatal evaluation at 32 weeks was requested for whole exome sequencing (WES).,Not Specified,The UnitedHealthcare policy’s prenatal WES coverage criteria do not specify gestational- or fetal-age limits; no age-based restriction for a 32-week fetus is stated.,No,"Prenatal WES coverage requires the test be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist; the request was made by a neonatologist (patient data), so the ordering provider requirement is not met per the policy.",No,"Policy prenatal WES is covered only when fetus has one or more defined findings (multiple congenital anomalies affecting different organ systems, fetal hydrops of unknown etiology, or a single-system congenital anomaly with family history suggestive of genetic etiology). The record does not document any of these fetal findings; consanguinity and family history are present but do not by themselves meet the prenatal WES fetal-anomaly criteria in the policy.",No,"Policy requires chromosome microarray analysis (CMA) and/or karyotyping to have been performed and uninformative prior to prenatal WES. Patient had prior FISH testing that was nondiagnostic, but CMA/karyotype are not documented, so required prior testing is not completed per policy.",Yes,"The policy lists consanguinity as an indication supporting WES (general criteria). Patient information documents parental consanguinity and a family history (sibling sudden unexplained death), so relevant family history/consanguinity is present.",Not Specified,"The policy states genetic counseling is strongly recommended prior to WES but does not make pre-test counseling an explicit coverage requirement for prenatal WES; the record notes no counseling was completed, but counseling is not specified as a mandatory coverage criterion.",81415,"Policy applicable CPT codes list 81415 for exome (sequence analysis), which corresponds to WES.",No,"Per the UnitedHealthcare prenatal WES coverage criteria the request fails multiple requirements: CMA/karyotype not documented as performed and uninformative, the ordering provider is a neonatologist rather than a medical geneticist or maternal-fetal medicine specialist, and the fetus lacks documented qualifying anomalies. Therefore prenatal WES is not covered under the policy as presented.",36957,2174,39131
Case6867,rag,all_correct,iter2,BRCA1/2,Patient explicitly presents for BRCA1 and BRCA2 testing per the clinical information; policy addresses BRCA1/BRCA2 testing as the relevant coverage category.,Yes,"Policy includes age-based criteria but also states that a person with a personal history of breast cancer who is ""Diagnosed at any age with: ≥1 close blood relative with ... Metastatic or intraductal/cribriform prostate cancer"" qualifies. The patient is a breast cancer–affected individual with a brother with metastatic intraductal prostate cancer, so age is not a limiting factor under the applicable criterion.",Not Specified,"The policy requires testing be performed in a setting with suitably trained providers and access to CLIA‑licensed labs and recommends genetic counseling, but it does not specify a required ordering provider type or specialty (the ordering NP is neither accepted nor excluded explicitly).",Yes,"Policy states testing is medically necessary for individuals with personal history of breast cancer and who are ""Diagnosed at any age with: ≥1 close blood relative with ... Metastatic or intraductal/cribriform prostate cancer."" The patient has that family history (brother with metastatic intraductal prostate cancer).",Not Specified,The policy recommends testing an affected relative first when possible but does not require any specific prior laboratory testing be completed before BRCA1/2 germline testing for an affected individual; no mandatory prior tests are specified for this scenario.,Yes,Patient has relevant family history: a brother with metastatic intraductal prostate cancer and a mother with breast cancer at age 50; the policy specifically lists close relatives with metastatic or intraductal prostate cancer and family breast cancer as qualifying family-history criteria.,Yes,"Policy requires testing to be performed in a setting able to provide appropriate pre- and post-test counseling and recommends formal genetic counseling; the patient has had multiple pre-test counseling visits with a genetic counselor, meeting the policy's counseling expectation.",Not Specified,The provided policy text does not specify or map procedural CPT codes for BRCA1/2 testing; no CPT code assignment is given in the document.,Yes,"Per the policy, BRCA1/BRCA2 testing is medically necessary for an individual with a personal history of breast cancer who has a close blood relative with metastatic or intraductal prostate cancer. The patient meets this criterion, has documented genetic counseling, and no policy exclusions prevent coverage.",18950,2337,21287
Case1130,rag,all_correct,iter2,WES,"Patient info states the patient ""is undergoing whole exome sequencing (WES)"" — WES is explicitly requested.",Not Specified,"The policy does not set a single age cutoff for WES; it includes age‑dependent clinical criteria (e.g., ID diagnosed by 18y, epileptic encephalopathy onset <3y) but no blanket age eligibility. The patient is 68 and no policywide age exclusion is specified.",Not Answerable,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. Patient data only notes referral by cardiology and does not state the actual ordering provider specialty, so ability to verify ordering‑provider requirement cannot be determined from the provided information.",No,"Coverage requires meeting specific clinical indications (e.g., epileptic encephalopathy onset <3y, or clinical history strongly suggesting genetic cause plus specified features). The patient has persistent seizures but no documentation of early‑onset epileptic encephalopathy, developmental delay, multisystem congenital anomalies, consanguinity, or two or more listed supporting features — patient therefore does not meet the policy's defined medical indications.",Not Specified,"The policy does not mandate specific prior tests for outpatient WES in this adult seizure scenario (except when a specific syndrome is suspected or for prenatal WES). Patient had nondiagnostic FISH, but no required prior testing is specified for this indication in the policy.",No,"The policy lists relevant family history (e.g., other first‑ or second‑degree relatives with similar clinical features) as a supporting criterion. The patient reports a sister with ovarian/fallopian tube/peritoneal carcinoma, which is not a similar phenotype to the proband’s seizures, so the family history does not meet the policy's relevant familial‑phenotype criterion.",Yes,"Policy states genetic counseling is strongly recommended prior to WES. The patient ""has seen a genetic counselor multiple times with plans for post-test follow-up,"" which meets the policy's counseling recommendation.",81415,Policy's applicable CPT codes list 81415 for exome sequence analysis (WES); this code best corresponds to the requested WES.,No,"Per the policy, WES is covered only when specific clinical criteria are met and when ordered by specified specialists. The record lacks documentation that the clinical indications in the coverage rationale are met (no qualifying early‑onset epileptic encephalopathy, developmental delay, or two or more supporting features), and the ordering provider specialty is not documented as one of the required specialties. Therefore coverage criteria are not satisfied.",36951,2495,39446
Case5303,rag,all_correct,iter2,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing; clinical note explicitly requests BRCA1/2.,No,"Policy includes age-based criteria (e.g., BRCA1/2 testing proven necessary for individuals with breast cancer diagnosed ≤65). The patient is 37 but has no personal history of breast (or other listed) cancer, so she does not meet the policy's age-linked eligibility requirements for BRCA testing.",Not Specified,"Policy recommends evaluation by providers with genetics expertise and recommends pre-test counseling, but it does not state a specific required ordering provider specialty for coverage of BRCA1/2 testing.",No,"Coverage criteria require a qualifying personal or family cancer history (e.g., personal breast/ovarian/pancreatic/prostate cancer, or specific affected relatives). Patient has no personal history of a primary solid tumor and family history (brother died suddenly <35) does not meet any listed BRCA-related family history criteria.",Not Specified,"The policy does not mandate completion of specific prior tests (e.g., prior genetic testing or tumor testing) universally before BRCA1/2 testing in unaffected individuals; no required prior testing is specified for this scenario.",No,"Policy specifies family-history criteria for BRCA testing (first-/second-degree relatives with breast ≤50, ovarian, pancreatic, male breast, etc.). The patient’s family history (brother died suddenly before 35, no cancer history reported) does not meet those specified family-history criteria.",Not Specified,"Policy states pre-test genetic counseling is strongly recommended but does not make counseling a formal coverage requirement; patient had no pre-test counseling, and the policy does not require counseling as a condition of coverage.",81162,Policy Applicable Codes list CPT 81162 for BRCA1/BRCA2 full sequence analysis with full duplication/deletion analysis; this best corresponds to BRCA1/2 testing requested.,No,"Under the UnitedHealthcare policy, BRCA1/2 testing is covered when specific personal or qualifying family cancer history criteria are met. This patient has no personal history of a qualifying primary solid tumor and her reported family history does not meet any listed BRCA-related family criteria; therefore BRCA1/2 testing is not covered per the policy.",38601,2559,41160
Case7447,rag,all_correct,iter2,WGS,The clinical info states the cardiologist ordered whole genome sequencing (WGS).,No,"Policy age-related eligibility addresses children and critically ill neonates/infants; this request is prenatal (33 weeks' gestation) and the policy explicitly excludes prenatal (fetal) testing, so the patient's age/setting does not meet specified criteria.",No,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling before WES/WGS; the ordering provider is a cardiologist and there is no documentation of genetics evaluation, so ordering requirements are not met.",No,"Policy defines medical indications for postnatal WES/WGS (unexplained congenital or neurodevelopmental disorders in children or critically ill infants); it also explicitly excludes prenatal (fetal) testing, so the fetal isolated CHD does not meet the policy's defined indications.",No,"Policy indicates WES/WGS is for cases after standard workup (eg, chromosomal microarray and/or targeted single-gene testing) or when prior testing failed; only fragile X (nondiagnostic) was done and there is no documentation of CMA or other prior appropriate genetic testing.",No,"Policy lists family-history criteria relevant to WES/WGS (eg, arrhythmia, developmental delay, sudden unexplained death); the provided family history (maternal aunt with triple-negative breast cancer) is not among the specified relevant family-history criteria.",No,Policy requires genetic counseling by an experienced clinician prior to testing; there is no documentation of pre-test genetic counseling in the patient information.,Not Specified,"The provided policy text does not list or map CPT codes to WES/WGS, so a specific CPT code cannot be determined from the policy.",No,"The policy explicitly excludes prenatal (fetal) testing and restricts WGS/WES coverage to postnatal indications (children/critically ill infants) with required genetics evaluation and prior testing; those conditions are not met for this prenatal WGS request, so it is not covered per policy.",14825,1993,16818
Case16126,rag,all_correct,iter2,BRCA1/2,Patient information states BRCA1 and BRCA2 testing has been ordered. Basis: the patient's clinical info explicitly names BRCA1/BRCA2.,No,"Policy explicitly states genetic testing in minors for BRCA1/BRCA2/PALB2 is considered investigational. The patient is a 6‑week‑old infant (minor), so age does not meet policy age-related eligibility. Basis: FEP policy 'Testing Minors' statement.",Yes,"Policy requires testing be performed in a setting with suitably trained providers who can give pre‑ and post‑test counseling. Patient had pre‑test counseling and plans post‑test follow up with a genetic counselor, satisfying the policy's provider/counseling setting requirement. Basis: policy 'Genetic testing should be performed in a setting that has suitably trained health care providers ... pre- and post-test counseling'.",No,Policy medical indications for BRCA1/2 testing are personal cancer history or family history suggesting HBOC or other listed criteria. The infant has no personal or family cancer history meeting those criteria. Basis: policy 'Individuals With Cancer or With a Personal History of Cancer' and 'Individuals Without Cancer' criteria.,Not Specified,"Policy provides recommended testing strategies (eg, test an affected family member first) but does not define a specific required prior test (FISH is not listed). The policy does not explicitly require any prior test in this clinical scenario. Basis: policy 'Recommended Testing Strategies' and testing-unaffected guidance.",No,"Policy specifies family cancer history criteria for BRCA testing (first/second/third‑degree relatives with cancer). The patient record does not report a qualifying family cancer history. Although parents are consanguineous, consanguinity is not listed as a BRCA testing eligibility criterion in the policy. Basis: policy family history/close relatives definitions and testing criteria.",Yes,"Policy recommends formal genetic counseling and that testing occur where pre‑ and post‑test counseling is available. Patient had pre‑test counseling and plans post‑test follow‑up with a genetic counselor, meeting policy counseling requirements. Basis: policy 'Genetic Counseling' statements and requirement for pre/post counseling.",Not Specified,The provided policy document does not list or map BRCA testing to any CPT codes. No CPT guidance is given in the policy text. Basis: absence of CPT code information in the FEP policy.,No,"Under the FEP policy, genetic testing for BRCA1/2 in minors is considered investigational (not covered). Additionally, the patient does not meet the policy's medical indications (no relevant personal or family cancer history). Although counseling requirements are met, the investigational status for minors and lack of medical indication lead to noncoverage. Basis: policy 'Testing Minors' (investigational) and medical necessity criteria for BRCA1/2 testing.",18931,2490,21421
Case4512,rag,all_correct,iter2,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,No,Policy medical-necessity statements apply to 'children' (pediatric) for standard WES/WGS; patient is 21 years old and therefore does not meet the age-based pediatric eligibility described in the policy.,No,Policy requires documentation that the individual 'has been evaluated by a clinician with expertise in clinical genetics' (Policy Statement #1). Patient record documents referral by a PCP and pre-test counseling by a genetic counselor but does not document evaluation by a clinician with expertise in clinical genetics.,No,"Policy defines medical indications for WES/WGS in children with unexplained congenital anomalies or neurodevelopmental disorders; the patient is an adult (age 21) and thus does not meet the policy's defined pediatric medical-indication criteria. Additionally, the policy states WGS is investigational 'in all other situations.'",Not Specified,"Policy specifies prior testing (eg, CMA and/or targeted single-gene testing) as part of criteria for standard WES in children, but does not define prior-test requirements specific to non-rapid WGS in this adult scenario; patient has no prior genetic testing.",Yes,"Policy explicitly lists 'BRUE in sibling' under relevant family history examples. Patient has a sibling with a BRUE-like event, which matches the policy's listed family-history criterion.",Yes,"Policy requires counseling: 'Documentation ... counseled about the potential risks of genetic testing' and recommends formal genetic counseling. Patient completed pre-test counseling with a genetic counselor and has a post-test visit planned, meeting the counseling requirement.",Not Specified,The provided policy document does not list or map CPT codes to WGS/WES; therefore a specific CPT code cannot be determined from the policy text.,No,"Per the policy, WGS is considered investigational for diagnosis 'in all other situations' and standard WES/WGS medical-necessity criteria apply to children. The patient is an adult (age 21), ordering-provider genetics-evaluation requirement is not met, and thus WGS is not covered under the policy.",14859,2527,17386
Case1778,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) has been requested.,Yes,"Policy requires member be <21 years of age for ES; patient is 14, which meets the <21 years requirement (MOL.TS.235.C).",Not Specified,The policy requires an appropriate genetic and family history evaluation and a clinical letter but does not specify a required ordering provider specialty/type for ES; no explicit ordering-provider credential requirement is stated.,No,"Policy requires specific indications (e.g., global developmental delay, multiple congenital anomalies affecting different organ systems, or two-of-listed neurodevelopmental criteria). The patient has an isolated ocular coloboma (single organ system) and does not meet the listed indications for ES in the guideline.",Not Answerable,"Policy requires documentation of prior genetic/family history evaluation and previous tests; patient record notes only prior nondiagnostic FISH and does not document the required clinical letter or other prior tests (e.g., CMA or targeted testing) needed to assess compliance with prior-test requirements.",Not Specified,The general ES criteria do not set family history or consanguinity as a universal eligibility requirement for ES (except specific prenatal scenarios). No relevant family history/consanguinity is provided in the patient information.,No,Policy/ACMG guidance requires pretest counseling by a medical geneticist or genetic counselor and documentation; the patient information does not document that required genetic counseling or the clinical evaluation letter has occurred.,81415,Policy specifies CPT 81415 should be billed for proband exome sequencing (analyzing the entire exome).,No,"Although age criterion is met, the patient does not meet the policy's defined medical indications for ES (isolated ocular coloboma does not satisfy multiple congenital anomalies or neurodevelopmental criteria), and required documentation of genetic evaluation/counseling and prior testing is not provided. Per the guideline, these unmet criteria make ES not medically necessary/covered.",10435,2238,12673
Case14155,rag,all_correct,iter2,WGS,Patient record explicitly states 'whole genome sequencing (WGS) has been requested.',Yes,"Policy requires member <21 years for genome sequencing; patient is 7 years old, meeting the age criterion (policy: 'Member is <21 years of age').",Not Specified,The policy requires the rendering laboratory be a qualified provider per plan but does not specify a required ordering provider specialty/type; neurology referral is noted but policy does not define ordering-provider requirements.,No,"Policy requires the phenotype to meet specified clinical criteria (e.g., GDD under age 5, moderate/severe ID, multiple anomalies, or TWO listed criteria including autism plus another feature). The patient has a formal autism diagnosis only and no additional required neurodevelopmental features or formal ID/GDD per the policy, so does not meet the medical-indication criteria.",No,"Policy requires no prior ES/GS AND 'appropriate genetic and family history evaluation' with a clinical letter detailing differential, testing algorithm, prior tests/results, etc. Patient has no prior genetic testing but pre-test genetic evaluation/documentation was not completed (pre-test counseling was declined), so required evaluation/documentation is incomplete.",Not Specified,"The standard genome sequencing criteria do not list family history or consanguinity as a standalone eligibility criterion (family history appears only in the rWGS inpatient criteria), so family history is not specified as a criterion for the requested GS in this policy.",No,"Policy/ACMG guidance requires pretest genetic counseling and documentation as part of 'appropriate genetic and family history evaluation'; the family declined pre-test genetic counseling, so counseling requirements are not met.",81425,Policy specifies CPT 81425 should be billed for the proband when analyzing the entire genome sequence (WGS/GS).,No,"Although age and lack of prior ES/GS are met, the policy requires documented appropriate genetic/family history evaluation and that the clinical presentation meet specified diagnostic criteria; pre-test counseling/documentation was not completed and the patient does not meet the policy's defined clinical indication, therefore GS is not covered per the policy.",9161,1946,11107
Case13406,rag,all_correct,iter2,WGS,Patient info states whole genome sequencing (WGS) has been ordered by a medical geneticist.,Yes,"Policy age-related criteria allow testing for Global Developmental Delay (onset prior to 5 years); the patient is 6 weeks old, meeting the age/onset criterion for GDD in the policy.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the test was ordered by a medical geneticist.",Yes,Policy lists Global Developmental Delay as a listed clinical indication for WGS/WES; the patient is being evaluated for global developmental delay.,No,"Policy explicit requirement for WGS: 'Neither CMA nor WES have been performed.' The patient had a prior CMA (nondiagnostic), so this prior-test requirement for WGS is not met.",No,"Policy notes family history/consanguinity can be a supporting feature, but the policy’s family-history criterion is 'other first- or second-degree family member(s) with similar clinical features.' The sibling’s brief resolved unexplained event is not the same as the proband’s global developmental delay, so the policy family-history criterion is not met.",Not Specified,"Policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling a formal coverage requirement; patient had pre-test counseling, but counseling is not specified as a required coverage criterion.",81425,Policy applicable CPT for genome (WGS) sequence analysis is 81425 (Genome; sequence analysis).,No,"Although patient meets age, provider, and clinical indication criteria for genomic sequencing, policy coverage for WGS requires that neither CMA nor WES have been performed. The patient had a prior CMA (nondiagnostic), therefore WGS is not covered per the policy.",36966,2084,39050
Case3581,rag,all_correct,iter2,BRCA1/2,Patient information states 'BRCA1 and BRCA2 testing has been ordered.' Basis: patient clinical info.,Yes,"Policy criteria for BRCA analysis require 'Age 18 years or older' for known familial, founder, and full sequence testing. Patient is 69, meeting the age requirement. Basis: policy 'Age 18 years or older' and patient age.",Not Specified,Policy requires the rendering laboratory be a qualified provider and refers to 'appropriate provider' for counseling but does not specify ordering provider specialty/type. Basis: policy text on provider/lab requirements; no explicit ordering-provider specialty requirement provided.,No,"Policy's medical indications for BRCA testing are cancer diagnoses or family history criteria (breast, ovarian, prostate, pancreatic, Ashkenazi founder contexts, or known familial BRCA mutation). Patient has no personal or family history of these cancers and presentation is hearing/visual impairment and a sibling BRUE. Basis: policy 'Diagnostic Testing for Symptomatic Individuals' and 'Personal & Family History Combination' criteria vs. patient facts.",Yes,"Policy requires 'No previous full sequencing of BRCA1/2' (i.e., absence of prior BRCA full sequencing) for full sequence testing; patient has no prior BRCA testing (prior FISH was nondiagnostic and is not BRCA sequencing). Basis: policy 'Previous Genetic Testing' requirements and patient facts.",No,Policy specifies family-history criteria (first-/second-/third-degree relatives with breast/ovarian/pancreatic/prostate cancers or known BRCA mutation). Patient's family history (sibling with BRUE) does not meet those specified family-history criteria. Basis: policy family-history definitions and criteria vs. patient facts.,No,Policy requires 'Pre- and post-test genetic counseling by an appropriate provider' for BRCA testing. Patient has had no pre-test genetic counseling. Basis: policy 'Genetic Counseling' requirement and patient facts.,81162,"Policy lists CPT 81162 for 'BRCA1/2 full sequencing and duplication/deletion analysis (combined)' and notes when sequencing and deletion/duplication are performed concurrently 81162 is likely most appropriate. Patient ordered BRCA1/2 testing (no separate specification), so 81162 best corresponds. Basis: policy procedures table and billing guidance.",No,"Coverage requires meeting defined clinical indications (personal/family cancer history or known familial mutation) and pre-test genetic counseling. Patient does not meet the policy's medical indication criteria (no relevant cancer history or known family BRCA mutation) and has not had required pre-test genetic counseling, so testing is not covered per the policy. Basis: policy medical-indication and genetic-counseling requirements and patient facts.",10276,1948,12224
Case10529,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy age criteria allow WES for intellectual disability diagnosed by age 18; the patient is 6 years old with ID/DD, so age criterion is satisfied (Policy: WES indicated for ID diagnosed by 18).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; patient was referred by neurology (neurologist ordering meets policy requirement).",Yes,"Policy requires nonspecific presentation plus one of listed features (e.g., intellectual disability or global developmental delay, or neurologic abnormalities/family members with similar features). Patient has nonsyndromic developmental delay/intellectual disability and a maternal uncle with dystonia/ataxia, meeting policy clinical indications.",Not Specified,"Policy does not mandate specific prior tests for postnatal WES in this scenario (it advises targeted testing if a specific syndrome is suspected); patient had Fragile X testing nondiagnostic, but policy does not require additional specific prior tests for WES here.",Yes,Policy lists other first- or second-degree family members with similar clinical features as a criterion; patient has a maternal uncle with dystonia and ataxia (relevant second-degree family history).,Not Specified,"Policy 'strongly recommends' genetic counseling but does not make counseling an explicit coverage requirement; patient has documented pre-test counseling and planned post-test follow-up, but counseling is not specified as a mandatory coverage criterion in the policy.",81415,"Policy lists CPT 81415 for exome sequence analysis (proband exome), which corresponds to the requested WES.",Yes,"Under the policy WES is proven/medically necessary when criteria are met: nonsyndromic presentation, ordered by an approved specialist (neurologist), and presence of ID/DD and relevant family history — all met by this patient, so WES is covered per policy.",36949,1859,38808
Case18821,rag,all_correct,iter2,WES,Patient info states the obstetrician requests fetal whole exome sequencing (WES) at 22 weeks' gestation.,No,"Policy age-based eligibility is specified for children and critically ill infants (standard WES for children; rapid WES for NICU/PICU infants). The patient is a fetus (prenatal), which does not meet those age/setting criteria (Policy: 'This policy does not address ... prenatal (fetal) testing').",No,Policy requires evaluation by a clinician with expertise in clinical genetics including counseling (Policy Statement criterion 1). The ordering provider is an obstetrician and there is no documentation of evaluation by a genetics clinician or documented pre-test genetic counseling.,Yes,"Policy lists multiple congenital anomalies as a clinical indication (examples in Policy Guidelines) for WES/rWES. The fetus has multiple congenital anomalies affecting different organ systems, meeting the phenotype-based indication regardless of other eligibility requirements.",No,"Standard WES criteria require prior genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) or prior testing failure (Policy Statement criterion 3). The patient has no prior genetic testing.",Yes,"Policy requires documentation of a family history as part of evaluation (Policy Statement criterion 1 and Policy Guidelines). The patient has a reported maternal aunt with dysmorphic features, which constitutes a family history.",No,Policy requires counseling by a clinician with expertise in clinical genetics prior to testing (Policy Statement criterion 1 and 'Genetic Counseling' section). There is no documentation of pre-test genetic counseling.,81415,Requested test is whole exome sequencing; CPT 81415 corresponds to exome sequencing (whole exome) for billing of WES.,No,"The policy explicitly does not address prenatal (fetal) testing ('This policy does not address ... prenatal (fetal) testing') and defines medical necessity for WES in children/critically ill infants with specific requirements (genetics evaluation, counseling, prior testing). The patient (fetal WES) does not meet the applicable policy age/setting, provider/counseling, or prior-testing requirements, so coverage is not supported under this policy.",14844,2476,17320
Case5230,rag,all_correct,iter2,WES,Patient record explicitly states 'whole exome sequencing (WES)' was referred/ordered.,Yes,"Policy includes age-based criteria for some features (e.g., ID or impairments diagnosed by 18 years). The patient is 15 years old, which meets the policy's age thresholds where specified and presents no age-based exclusion for postnatal WES.",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the referral was from neurology, meeting the ordering-provider requirement.",Yes,"Policy requires clinical history that strongly suggests a genetic cause plus specific features. The patient has a congenital anomaly and a first‑degree family history of an inborn error of metabolism (two policy-listed features), and WES is being used to evaluate an unexplained congenital anomaly—meeting the medical indication.",Not Specified,"The WES policy does not mandate specific prior tests in the non‑prenatal/postnatal setting (except targeted testing if a specific syndrome is suspected). Although CMA was done and nondiagnostic, the policy does not require a particular prior test universally for WES.",Yes,"Policy lists family history/other affected first‑ or second‑degree relatives as a qualifying feature. The patient has a sibling with an inborn error of metabolism, which is relevant per the policy.",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not state counseling is a required coverage criterion; the patient declined counseling, which the policy does not make a coverage exclusion.",81415,"Policy's applicable CPT list maps WES (exome sequence analysis, proband) to CPT 81415 for primary exome sequencing.",Yes,"Per UnitedHealthcare WES coverage rationale, WES is medically necessary when ordered by an approved specialist and the clinical history suggests a genetic cause with qualifying features. The patient (age 15) was referred by a neurologist, has a congenital anomaly and relevant family history, and CMA was nondiagnostic — meeting policy coverage criteria.",36915,2579,39494
Case6478,rag,all_correct,iter2,BRCA1/2,Patient is being referred for germline BRCA1 and BRCA2 testing per the clinical information. Basis: patient referral information (requested test) and policy groups BRCA1/2 testing under hereditary cancer testing.,Not Specified,"The policy specifies age criteria for BRCA1/2 testing in the context of breast cancer (e.g., ≤65) but does not impose an age limit for BRCA1/2 testing when the indication is metastatic prostate cancer. Basis: UnitedHealthcare policy coverage rationale listing 'metastatic prostate cancer' as an indication without age restriction.",Not Specified,"The policy strongly recommends genetic counseling and involving providers with genetics expertise but does not state a specific mandatory ordering provider specialty for BRCA1/2 testing. Basis: 'Pre-test genetic counseling is strongly recommended' and guidance that providers familiar with hereditary cancer should conduct evaluations, without a strict ordering-provider requirement.",Yes,"Patient has metastatic prostate cancer, which the policy explicitly lists as a clinical indication for germline hereditary cancer testing (including BRCA1/2). Basis: Coverage Rationale: 'Metastatic prostate cancer' included among personal history criteria for testing.",Not Specified,"The policy does not require completion of specific prior tests (e.g., tumor testing) before germline BRCA1/2 testing for metastatic prostate cancer; no prior-test prerequisite is specified. Basis: Coverage Rationale lists indications but does not mandate prior testing for this scenario.",Yes,"Policy recognizes pancreatic cancer as a BRCA-related cancer; the patient’s father had pancreatic cancer (a first‑degree relative), which is relevant to eligibility. Basis: Definitions and coverage rationale list pancreatic cancer as a BRCA-related cancer and family history criteria.",Not Specified,"The policy 'strongly recommends' pre-test genetic counseling but does not make counseling an absolute coverage requirement; the patient did not have pre-test counseling, but counseling is not mandated for coverage per the policy text. Basis: 'Pre-test genetic counseling is strongly recommended...' in Coverage Rationale.",81162,"CPT 81162 corresponds to BRCA1/BRCA2 full sequence analysis plus full duplication/deletion analysis, which matches the requested germline BRCA1/2 testing. Basis: Applicable Codes section lists 81162 for BRCA1 and BRCA2 full sequence and duplication/deletion analysis.",Yes,Patient meets policy coverage criteria: personal history of metastatic prostate cancer (explicitly listed) and relevant family history (father with pancreatic cancer). Counseling is recommended but not required. Basis: UnitedHealthcare Coverage Rationale and Prostate Cancer testing criteria listing metastatic prostate cancer and BRCA-related family history as indications for germline testing.,38617,1810,40427
Case13613,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) is being requested for prenatal evaluation of fetal anomalies.,Not Specified,"The UnitedHealthcare policy specifies age-related criteria for some postnatal indications (e.g., ID diagnosed by 18 years) but the prenatal WES coverage criteria do not include an age/gestational-age cutoff; therefore age-based eligibility is not specified for this prenatal WES request.",Yes,"Policy requires prenatal WES to be ordered by or in consultation with a medical geneticist or maternal-fetal medicine specialist; the record documents a pre-test discussion with a genetic specialist, satisfying the ordering/provider requirement per policy.",Yes,"Policy lists 'multiple congenital anomalies (must affect different organ systems)' as an accepted prenatal indication for WES. The fetus has multiple structural anomalies on imaging, meeting this clinical indication.",No,"UnitedHealthcare prenatal WES coverage requires CMA and/or karyotyping have been performed and were uninformative; the patient record documents only Fragile X testing (nondiagnostic) and does not document prior CMA or karyotype, so the required prior testing is not completed per policy.",Yes,"Policy lists family history (other first- or second-degree family member(s) with similar clinical features) as relevant. The patient has a maternal aunt with dysmorphic features, which is relevant per policy.",Yes,"Policy strongly recommends genetic counseling and for prenatal WES requires ordering by or in consultation with a medical geneticist/MFM. The record documents pre-test discussion with a genetic specialist, meeting the counseling/provider requirement.",81415,"UnitedHealthcare policy's applicable codes list CPT 81415 as the code for exome (sequence analysis), corresponding to WES.",No,"Although clinical indication (multiple fetal anomalies) and consultation with a genetic specialist are present, the policy requires prior CMA and/or karyotype to have been performed and uninformative and specific fetal sample sources to be used for prenatal WES. The record does not document prior CMA/karyotype or the required sample source, so full prenatal WES coverage criteria are not met per the policy.",36940,2012,38952
Case5380,rag,all_correct,iter2,WGS,Patient information explicitly states 'whole genome sequencing (WGS) is requested.',Yes,"Policy lists age-related qualifying features (e.g., 'epileptic encephalopathy with onset before three years of age'); the infant is 8 weeks old, which meets the <3 years onset criterion.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was referred by neurology (neurologist ordering), meeting this requirement.",Yes,Policy medical-indication criteria include 'epileptic encephalopathy with onset before three years of age' or similar neurologic abnormalities; the infant has recurrent seizure-like episodes/BRUE consistent with an early-onset seizure phenotype meeting that criterion.,No,"Policy states WGS is proven/medically necessary when 'Neither CMA nor WES have been performed.' The patient had prior CMA testing (nondiagnostic), so the WGS prior-test criterion is not met.",No,"The policy specifies family-history/consanguinity criteria (e.g., 'other first- or second-degree family member(s) with similar clinical features' or consanguinity). The record notes maternal short stature but not a first-/second-degree family member with similar proband features or consanguinity, so relevant family-history criteria are not met.",Not Specified,"Policy states 'Genetic counseling is strongly recommended prior to WES or WGS' but does not make pre-test counseling an explicit coverage requirement; the family declined counseling, but the policy frames counseling as recommendation rather than a coverage criterion.",81425,"Policy's Applicable Codes list 81425 as 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis,' which corresponds to WGS.",No,"Although age, provider, and clinical indication criteria are met (early-onset seizure phenotype, neurologist ordering), the policy requires that 'Neither CMA nor WES have been performed' for WGS to be medically necessary; the patient had prior CMA (nondiagnostic), therefore the WGS coverage criteria are not satisfied and the test is not covered per policy.",36943,2406,39349
Case15570,rag,all_correct,iter2,BRCA1/2,Patient record states the clinician requested BRCA1 and BRCA2 testing. Basis: patient clinical information.,No,"Policy explicitly states genetic testing in minors for BRCA1/2/PALB2 is considered investigational. Patient is 15 years old, so age-based eligibility is not met. Basis: FEP policy 'Testing Minors' statement.",No,Policy requires testing be performed in a setting with suitably trained providers who can give appropriate pre-/post-test counseling. Ordering provider is a general pediatrician with no documentation of genetic counseling or specialized qualification—requirements are specified and not met. Basis: 'Genetic testing should be performed in a setting that has suitably trained health care providers...' and Genetic Counseling section.,No,"Policy defines medical indications (personal/family history of cancers or meeting specified criteria). Patient has Hirschsprung disease, no personal cancer history, and no family cancer history; thus does not meet any defined indications. Basis: Policy statements for Individuals With/Without Cancer.",No,Policy strongly recommends testing an affected family member first for unaffected individuals. There is no documentation of prior testing of an affected family member; required prior testing strategy not completed. Basis: 'It is strongly recommended that an affected family member be tested first whenever possible.',No,"Policy specifies family history criteria are relevant for eligibility. Patient's family history shows only a mother with bipolar disorder and no cancer history, so family history criteria are not met. Basis: Policy family history requirements.",No,"Policy requires pre- and post-test genetic counseling by experienced providers. There is no documentation of pre-test genetic counseling for this patient, so counseling requirements are not met. Basis: 'Genetic counseling is primarily aimed... experts recommend formal genetic counseling...' and testing setting requirement.",Not Specified,The provided policy document does not specify CPT or billing codes for BRCA1/2 testing. Basis: reviewed policy text contains no CPT code mapping.,No,"Per policy, BRCA1/2 testing is investigational in minors and is medically necessary only when personal/family cancer history criteria are met. Patient is a minor (15), lacks personal or relevant family cancer history, has no documented genetic counseling, and testing was not done in a documented suitably trained setting—therefore not covered. Basis: 'Genetic testing in minors... considered investigational'; policy medical necessity criteria and genetic counseling/setting requirements.",18943,1817,20760
Case5834,rag,all_correct,iter2,CMA,Patient record explicitly states referral for chromosomal microarray (CMA) testing.,Not Specified,The policy describes CMA for individuals with developmental delay/ID but does not specify age-based eligibility limits; no age restriction in the policy text.,Not Specified,The policy does not state specific ordering-provider specialty or credential requirements for CMA; no provider-type requirement is specified in the policy text.,Yes,Policy states CMA may be medically necessary as first-line testing for 'apparent nonsyndromic developmental delay/intellectual disability'; the patient has lifelong severe intellectual disability consistent with this indication.,Not Specified,"Policy supports CMA as a first-line test and does not mandate completion of specific prior genetic tests (e.g., fragile X) before CMA as a coverage prerequisite.",Not Specified,The policy does not require family history or consanguinity for CMA eligibility; the patient's maternal history of ovarian cancer is not cited as a criterion in the policy.,Yes,Policy recommends formal genetic counseling when testing is considered and states counseling should be performed by experienced individuals; the patient had pre-test counseling by a genetic counselor and plans for post-test follow-up.,Not Specified,The policy document does not list or map CPT codes to CMA testing; no CPT code is specified in the provided policy text.,Yes,"Per the policy, CMA is medically necessary as first-line testing for individuals with apparent nonsyndromic intellectual disability; the patient meets this indication, has counseling, and no policy exclusion applies.",15715,1695,17410
Case1501,rag,all_correct,iter2,WES,Patient information explicitly states 'Whole exome sequencing (WES) is being ordered.' (Patient facts).,Yes,"Policy age criteria allow WES for global developmental delay (onset prior to 5 years) or ID diagnosed by 18. The patient is 2 years old with developmental concerns, meeting the age-based criteria (Policy: WES indications: 'Global Developmental Delay' and ID diagnosed by 18).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The ordering provider is a developmental pediatrician (Patient facts), meeting the policy requirement (Coverage Rationale).",Yes,"Policy lists 'Multiple congenital anomalies (must affect different organ systems)' and/or global developmental delay as qualifying clinical indications for WES. The patient has multiple congenital anomalies and developmental concerns with a nondiagnostic karyotype, satisfying the medical indication (Coverage Rationale).",Not Specified,"The policy does not mandate specific prior testing (e.g., CMA) before outpatient/postnatal WES; it only specifies prior testing in certain prenatal contexts. The patient had a nondiagnostic karyotype, but the policy does not state a required prior test for postnatal WES (Policy: WES coverage rationale and Prenatal section).",No,"The policy counts family history of similar clinical features as a relevant criterion. The patient’s family history is maternal Long QT syndrome, which is not described as 'other first- or second-degree family member(s) with similar clinical features' relevant to the patient's congenital anomalies/developmental phenotype; therefore the patient does not have the family-history criterion as defined (Coverage Rationale).",Not Specified,"The policy 'strongly recommends' genetic counseling prior to WES/WGS but does not impose it as a strict coverage requirement. The patient did have pre-test genetic counseling and plans post-test follow-up, but counseling is framed as recommendation (Description of Services), not an explicit mandatory coverage criterion.",81415,Policy lists CPT 81415 for exome sequence analysis (primary procedure) corresponding to WES (Applicable Codes).,Yes,"Based on policy: WES is medically necessary when results are expected to influence management, ordered by an approved specialist, and clinical criteria (multiple congenital anomalies/global developmental delay) are met. The patient is a 2‑year‑old with multiple congenital anomalies and developmental concerns, prior nondiagnostic karyotype, WES ordered by a developmental pediatrician, and pre-test counseling completed. These facts satisfy the policy coverage rationale for WES (Coverage Rationale; Applicable Codes).",36937,2568,39505
Case10427,rag,all_correct,iter2,WGS,Patient clinical info explicitly states whole genome sequencing (WGS) is being requested.,Yes,"Policy age-related features include 'hypotonia in infancy' as an accepted criterion for WGS; the patient is an 8‑week‑old infant with significant hypotonia, meeting the age-related feature per the WGS coverage rationale.",Yes,"Policy requires WGS be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the ordering provider is a neurologist, satisfying this requirement.",Yes,WGS coverage criteria require a nonspecific presentation and one (or two) listed features; the infant has nonspecific significant hypotonia (listed: 'Hypotonia or hypertonia in infancy') and family history of unexplained developmental regression — meeting the medical indication per the policy.,Yes,"The WGS coverage criteria state 'Neither CMA nor WES have been performed' as a condition for WGS; patient had only nondiagnostic FISH and has not had CMA or WES, satisfying this prior‑test requirement.",Yes,"Policy lists family history (other first/second‑degree members with similar features) and 'Unexplained developmental regression' as relevant features; patient has an older sibling with unexplained developmental regression, which is relevant per the policy.",Yes,"Policy 'strongly recommends' genetic counseling prior to WES/WGS; the patient had pre‑test counseling with a genetic counselor on multiple occasions and post‑test follow‑up is planned, meeting the counseling recommendation in the policy.",81425,"Policy's applicable codes list CPT 81425 for 'Genome (e.g., unexplained constitutional or heritable disorder or syndrome); sequence analysis' corresponding to WGS.",Yes,Under the UnitedHealthcare WGS coverage rationale the request meets all required elements: WGS ordered by an allowed specialist (neurologist); clinical presentation nonspecific with an accepted feature (hypotonia in infancy) and supporting family history; and neither CMA nor WES have been performed. Therefore WGS is covered per the policy.,36955,2323,39278
Case8485,rag,all_correct,iter2,WES,Patient record explicitly states 'whole exome sequencing (WES) has been ordered.',Yes,"Policy requirement: 'Member is <21 years of age.' Patient is 8 years old, meeting the age criterion (Cigna Exome Sequencing criteria).",Not Specified,The policy requires an 'appropriate genetic and family history evaluation' and a clinical letter but does not specify ordering-provider specialty or other explicit ordering provider requirements.,No,"Policy requires specific clinical indications (e.g., global developmental delay after formal assessment by developmental pediatrician/neurologist, multiple congenital anomalies, or other defined criteria). The patient has hypotonia and motor delay without documentation of the required formal assessments or meeting one of the listed phenotype criteria; thus the medical indication criteria are not met.",No,"Policy requires prior appropriate genetic/family history evaluation and documentation of previous tests and results. Patient has only nondiagnostic Fragile X noted and no documentation of the required clinical letter, formal specialist assessment, or other prior testing (e.g., CMA or documented targeted workup) required by the guideline.",Not Specified,"The guideline requires inclusion of family history in the evaluation but does not define specific family-history/consanguinity criteria that alone confer eligibility. Patient has a sibling with ASD, but the policy does not state this specific family history makes the member eligible.",No,"ACMG guidance cited in the policy and the Cigna criteria require appropriate genetic evaluation/pretest counseling; patient record states pre-test genetic counseling was not performed, so counseling requirements are not met.",81415,Policy billing section: '81415 should be billed for the proband' when analyzing the entire exome (exome sequencing/WES).,No,"Although age and proband CPT mapping are satisfied, the Cigna Exome criteria require ALL conditions (no prior ES/GS, appropriate genetic/family history evaluation with a clinical letter, meeting one of the defined phenotype indications, etc.). The patient lacks documented specialist assessment/clinical letter, required phenotype criteria, and pretest genetic counseling, so the test does not meet all coverage criteria.",10471,2458,12929
Case11795,rag,all_correct,iter2,WES,Patient information states whole exome sequencing (WES) is being ordered after nondiagnostic CMA.,Yes,"Policy specifies WES/WGS eligibility for children/infants; the patient is a three-week-old infant, which meets the age-related scope in the policy.",Not Answerable,Policy requires evaluation by a clinician with expertise in clinical genetics. The patient info notes referral by a cardiologist and pre-test genetic counseling but does not state whether a clinician with clinical genetics expertise performed the required evaluation.,Yes,Policy lists infants with high-risk BRUE and significantly abnormal ECG (possible channelopathies/arrhythmias/cardiomyopathy) as clinical features suggesting a genetic disease; the patient has high-risk BRUE and a markedly abnormal ECG.,Yes,"Policy requires prior genetic testing (eg, CMA) to be nondiagnostic before WES; the patient had a CMA previously performed and nondiagnostic.",Yes,"Policy cites relevant family history (eg, developmental delay in relatives) as pertinent; the patient has a sibling with moderate–severe intellectual disability, which is a listed relevant family-history criterion.",Yes,"Policy requires genetic counseling; the patient had pre-test genetic counseling completed with plans for post-test follow-up, meeting the policy's counseling requirement.",Not Specified,"The provided BCBS_FEP policy text does not list or map CPT codes to WES or other tests, so a corresponding CPT code is not specified in the policy document.",Yes,"Per the policy, WES may be medically necessary when (a) evaluated and counseled about testing, (b) prior genetic testing (CMA) is nondiagnostic, and (c) a genetic etiology is considered likely with potential to change management. The patient has pre-test genetic counseling, nondiagnostic CMA, a high-risk BRUE with markedly abnormal ECG (a policy-listed feature suggesting genetic disease), and potential management implications; therefore the request meets the policy's medical necessity criteria. (Note: documentation of a clinician with expertise in clinical genetics was not explicitly provided in the patient info.)",14874,3025,17899
Case2007,rag,all_correct,iter2,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing (clinical information states BRCA1 and BRCA2 testing is being ordered).,Yes,"Policy lists personal history of breast cancer diagnosed at age ≤45 as a medical-necessity criterion; the patient is 18 (≤45), so age-based eligibility is met (and the patient is an adult, not a minor).",Yes,"Policy requires testing be performed in a setting with suitably trained providers who can give pre- and post-test counseling; the patient completed pre-test counseling and will return for post-test counseling, satisfying the provider/counseling setting requirement.",Yes,Policy explicitly lists 'personal history of breast cancer diagnosed at age ≤45 years' as an indication for BRCA1/2 testing; the patient (age 18 with metastatic breast cancer) meets this criterion.,Not Specified,The policy does not mandate specific prior tests be completed before BRCA1/2 testing (it notes strategies and that prior limited testing may alter approach) and does not require particular prior testing; the provided patient info (CMA nondiagnostic) is not required by policy.,Yes,"Policy specifies family-history criteria (eg, ≥1 close blood relative with breast cancer diagnosed ≤50 years) and the patient’s mother had breast cancer at age ≤50, which is relevant and meets family-history criteria.",Yes,"Policy states genetic testing should occur with appropriate pre- and post-test counseling by trained providers; the patient completed pre-test counseling and will return for post-test counseling, meeting counseling requirements.",Not Specified,"The provided policy document does not specify CPT or billing codes for BRCA1/2 testing, so no CPT in the provided list can be selected based on the policy text alone.",Yes,"Per the policy, BRCA1/2 testing is medically necessary for individuals with breast cancer diagnosed ≤45 and/or with a close relative with breast cancer ≤50; the patient is 18 with metastatic breast cancer and has a mother diagnosed ≤50, and counseling requirements are met, so testing is covered.",18944,1945,20889
Case7297,rag,all_correct,iter2,WES,Patient record states whole exome sequencing (WES) is being pursued.,Yes,"Policy includes pediatric age-based criteria (e.g., diagnosis by age 18 or onset <3 yrs) and WES is indicated for multiple congenital anomalies; the patient is 3 years old and therefore does not fail any age-based limits and fits pediatric criteria.",Not Answerable,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. Patient info states referral by a family medicine physician and pre-test counseling by a 'genetic specialist' but does not explicitly state who placed the WES order or whether that provider is one of the listed specialties.",Yes,"Policy lists 'multiple congenital anomalies (must affect different organ systems)' as a qualifying indication for WES; the patient has multiple congenital anomalies affecting different organ systems and prior karyotype was nondiagnostic, meeting the medical indication.",Not Specified,"Policy does not mandate a specific prior test for postnatal WES in this scenario (it requires targeted testing if a specific syndrome is suspected). Patient did have prior karyotype (nondiagnostic), but the policy does not explicitly require additional prior testing for multiple congenital anomalies.",No,"Policy specifies family history relevant for WES as first- or second-degree family members with similar clinical features or consanguinity. The only family history documented is a maternal aunt with ovarian cancer, which is not a first/second-degree relative with similar features or consanguinity, so it does not meet the policy's family-history criterion.",Yes,"Policy 'strongly recommends' genetic counseling prior to WES/WGS. Patient had pre-test counseling with a genetic specialist and plans for post-test follow-up, satisfying the counseling recommendation in the policy.",81415,CPT 81415 corresponds to exome sequence analysis (WES) per the policy's applicable codes list.,No,"Although the patient meets medical necessity criteria (multiple congenital anomalies, prior nondiagnostic karyotype) and counseling was completed, the policy explicitly requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The documentation provided does not explicitly confirm that an eligible ordering provider placed the WES order, so coverage cannot be confirmed under the policy.",36959,3204,40163
Case2666,rag,all_correct,iter2,BRCA1/2,Patient information states she is undergoing BRCA1/2 testing at the request of her obstetrician. Basis: patient clinical info.,Yes,Policy specifies testing in minors is investigational; the patient is 21 (an adult). Basis: FEP policy statement that testing minors is investigational and patient age = 21.,Not Specified,"Policy requires testing in a setting with suitably trained providers and that genetic counseling be performed by experienced personnel, but it does not mandate a specific ordering provider specialty. Basis: policy language on setting and counseling requirements.",Yes,"Policy permits testing for an unaffected individual who has a 1st-degree blood relative meeting any criterion in the 'Individuals With Cancer' section; the patient’s father has metastatic prostate cancer, which is explicitly listed. Basis: FEP policy criteria for unaffected individuals and patient family history.",Not Specified,Policy recommends testing an affected family member first when possible but does not state that prior testing of the affected relative is a required prerequisite. Basis: 'Testing Unaffected Individuals' and 'Recommended Testing Strategies' guidance.,Yes,"Policy specifies family history criteria; patient has a relevant 1st-degree relative (father) with metastatic prostate cancer, a qualifying family history. Basis: patient facts and policy listing metastatic prostate cancer as a qualifying cancer in relatives.",Yes,Policy requires pre- and post-test genetic counseling by experienced providers; patient reports pre-test counseling with a genetic specialist and plans for post-test follow-up. Basis: policy's genetic counseling requirement and patient report.,Not Specified,The provided FEP policy text does not list or map specific CPT codes to BRCA1/2 testing. Basis: absence of CPT code information in the policy document.,Yes,"Under the policy, genetic testing for BRCA1/2 is medically necessary for an unaffected individual who has a 1st-degree relative meeting any criterion for 'Individuals With Cancer'—the patient's father has metastatic prostate cancer (explicitly listed). Counseling requirement is met. Basis: FEP policy statements for unaffected individuals and the patient's family/counseling facts.",18944,2139,21083
Case13983,rag,all_correct,iter2,WGS,"Patient statement: ""whole genome sequencing (WGS) is being pursued"" — test explicitly requested is WGS.",Yes,Policy includes infants/children (rapid WGS/WES for critically ill infants; WES/WGS guidance applies to pediatric patients). Patient is a 7-week-old infant which meets the age category in the policy.,No,Policy criterion for standard testing requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. The ordering provider here is a gynecologist; there is no documentation the infant was evaluated by a clinician with expertise in clinical genetics (only pre-test counseling by a genetic counselor).,Yes,"Policy guidelines explicitly list ""Infant with high risk stratification on evaluation for a Brief Resolved Unexplained Event (BRUE) ..."" and ""Significantly abnormal electrocardiogram (ECG) ... possible channelopathies, arrhythmias, cardiomyopathies"" as clinical features suggesting a genetic disease. Patient has a high‑risk BRUE and a significantly abnormal ECG.",No,"For standard WES/WGS the policy expects prior genetic testing (eg, CMA and/or targeted single‑gene testing) or prior testing failure. The record shows only prior FISH (nondiagnostic); there is no documentation of CMA or targeted single‑gene testing required by the policy.",Yes,"Policy lists family history of developmental delay as relevant. Patient has a maternal uncle with unexplained developmental regression, which meets the family‑history criterion in the policy.",Yes,"Policy requires genetic counseling; patient had pre‑test counseling completed with a genetic counselor, satisfying the counseling requirement.",Not Specified,The provided policy document does not specify CPT codes for WGS/WES; no CPT mapping is given in the policy text.,No,"Although the clinical features (high‑risk BRUE with abnormal ECG and relevant family history) meet medical‑indication examples, the policy limits WGS coverage to rapid WGS for critically ill infants in NICU/PICU or WGS in specific pediatric contexts. There is no documentation the infant is critically ill/in NICU (required for rapid WGS), prior recommended genetic testing (eg, CMA) is not documented, and the genetic evaluation requirement by a clinician with genetics expertise is not documented. Based on the policy criteria, the requested WGS is not covered.",14898,3280,18178
Case15458,rag,all_correct,iter2,BRCA1/2,Patient is described as 'being evaluated for BRCA1 and BRCA2 testing' — the clinical information explicitly requests BRCA1/2 testing.,Yes,Policy lists 'personal history of breast cancer' diagnosed at age ≤45 years as a medical-necessity criterion; the patient is 19 and therefore meets the age-based criterion (Policy: 'Diagnosed at age ≤45 years').,Not Specified,"The policy requires testing be performed in a setting with suitably trained providers and CLIA-licensed labs and recommends genetic counseling, but it does not specify required ordering provider types or prohibit nurse practitioners from ordering testing.",Yes,"Policy lists personal history of breast cancer diagnosed ≤45 years and family history elements (ovarian cancer, metastatic/intraductal prostate cancer) as indications for BRCA1/2 testing; the patient meets these clinical criteria.",Not Specified,The policy discusses testing strategies and prior limited testing in some scenarios but does not require specific prior tests be completed before BRCA1/2 germline testing in this clinical situation.,Yes,Policy explicitly considers family history (first/second/third-degree relatives) including ovarian cancer and metastatic/intraductal prostate cancer as relevant criteria; the patient has a maternal aunt with ovarian cancer and a close relative with metastatic/intraductal prostate cancer.,Yes,"Policy requires appropriate pre- and post-test genetic counseling and states counseling should be performed by experienced providers; the patient completed pre-test genetic counseling with plans for post-test follow-up, satisfying the counseling requirement.",Not Specified,"The provided policy document does not list or reference specific CPT codes for BRCA1/2 testing, so a best-corresponding CPT code cannot be determined from the policy text.",Yes,"Per the policy, BRCA1/2 testing is medically necessary for individuals with a personal history of breast cancer diagnosed ≤45 years and with the described family history (ovarian and metastatic/intraductal prostate cancer). The patient meets these criteria and has documented pre-test counseling, so BRCA1/2 testing is covered under the policy.",18955,1754,20709
Case18868,rag,all_correct,iter2,WGS,Patient information states whole genome sequencing (WGS) has been ordered to assess hereditary cancer predisposition.,No,"Cigna GS criteria explicitly require the member to be <21 years of age; the patient is 41, so age criterion is not met (policy: 'Member is <21 years of age').",Not Answerable,"Policy requires an 'appropriate genetic and family history evaluation' and a detailed clinical letter. The record notes evaluation by a medical geneticist but the required clinical letter content is not provided, so inability to confirm that ordering/provider documentation meets policy requirements.",No,Policy defines specific medical indications (primarily pediatric neurodevelopmental/congenital criteria) and requires member <21; the adult patient with cancer does not meet the enumerated clinical/age indications in the policy.,Not Answerable,"Policy requires no prior exome/genome and documentation of prior testing in the clinical letter. While only a nondiagnostic karyotype is documented and no prior exome/genome is reported, the materials do not confirm all required prior testing/documentation per policy, so cannot verify compliance.",Yes,"Policy references family history as relevant to evaluation. The patient has a first-degree relative (mother) with a persistent severe hematologic disorder raising concern for a heritable syndrome, which is relevant family history.",No,"ACMG guidance cited in the policy requires pretest counseling by a medical geneticist or genetic counselor; the materials state there was no documented record of pre-test genetic counseling, so counseling requirements are not met in the documentation provided.",81425,Policy lists CPT 81425 for genome sequencing (proband) and states 81425 should be billed for whole genome sequence analysis.,No,"Coverage criteria require all listed conditions including member age <21 and detailed clinical documentation; the patient is 41 and the documentation of required clinical letter and pre-test counseling is lacking, therefore the test does not meet the policy's medical necessity criteria.",9161,2491,11652
Case10917,rag,all_correct,iter2,WES,Patient information states 'whole exome sequencing (WES) has been ordered.' Basis: patient clinical note.,Not Specified,The UnitedHealthcare WES policy does not impose a specific age limit for outpatient WES (criteria reference uses age only for features like diagnosis of ID by 18 years). Basis: policy Coverage Rationale does not specify an age cutoff for WES.,Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician; the patient was evaluated by a medical geneticist who ordered WES. Basis: policy 'WES is ordered by a medical geneticist…' and patient info.",Yes,Policy requires clinical history strongly suggestive of genetic cause plus specified features. The infant has persistent conjugated hyperbilirubinemia (a laboratory abnormality potentially suggestive of an IEM) and a first-degree family history (older sibling with multiple congenital anomalies) — meeting two listed features. Also presentation is nonspecific and WES was ordered by a medical geneticist. Basis: policy lists 'laboratory abnormalities suggestive of an inborn error of metabolism' and 'other first- or second-degree family member(s) with similar clinical features' as qualifying features.,Not Specified,The policy does not mandate specific prior tests for outpatient WES in this scenario (it only states targeted/single gene testing if a specific syndrome is suspected or specific prenatal CMA/karyotype requirements). No required prior testing is specified for this indication. Basis: policy Coverage Rationale.,Yes,Policy explicitly includes family history (other first- or second-degree family member(s) with similar clinical features) as a qualifying feature; patient has an older sibling with multiple congenital anomalies. Basis: policy features list and patient family history.,Yes,"Policy 'Genetic counseling is strongly recommended prior to WES or WGS.' Patient had pre-test counseling with a genetic specialist, meeting the counseling recommendation. Basis: policy Description of Services and patient info.",81415,Policy's Applicable Codes list maps exome sequence analysis to CPT 81415 for primary WES. Basis: policy Applicable Codes (81415 Exome; sequence analysis).,Yes,"All coverage criteria are met per policy: WES ordered by an authorized provider (medical geneticist), clinical presentation is nonspecific and suggests genetic etiology, and the patient has qualifying features (laboratory abnormality suggestive of IEM and relevant family history). Therefore WES is 'proven and medically necessary' per the policy Coverage Rationale. Basis: UnitedHealthcare WES Coverage Rationale and patient facts.",36946,2818,39764
Case12792,rag,all_correct,iter2,BRCA1/2,Patient was referred specifically for BRCA1/2 testing (clinical information states referral for BRCA1/2).,No,"Policy explicitly states genetic testing in minors for BRCA1/2/PALB2 is considered investigational; the patient is 12 years old, so age-based criterion is not met (policy = authoritative source).",Not Specified,"Policy requires testing be performed in a setting with suitably trained providers and access to a CLIA laboratory but does not specify a required ordering provider specialty; patient record notes referral by family medicine and pre-test counseling, but policy does not define an ordering-provider specialty requirement.",No,"Policy defines medical indications (personal or relevant family cancer history suggesting HBOC, or affected individuals meeting listed criteria). This patient is an unaffected minor with congenital choanal atresia and no reported family history of BRCA-related cancers, and testing in minors is considered investigational per policy, so clinical indications are not met.",Not Specified,"Policy strongly recommends testing an affected family member first when possible but does not mandate a specific prior test in all cases; the provided patient information only documents prior nondiagnostic FISH (not described by policy as required prior testing for BRCA1/2), so required prior testing is not specified by the policy for this scenario.",No,"Policy specifies family-history criteria relevant to eligibility (e.g., close blood relatives with breast/ovarian/pancreatic/prostate cancer). The patient’s data report a maternal growth abnormality but no family history of BRCA-related cancers, so relevant family-history criteria are not present.",Yes,"Policy requires appropriate pre- and post-test genetic counseling by experienced providers. The patient’s record documents that pre-test genetic counseling has been completed and post-test follow-up is planned, meeting the policy counseling requirement.",Not Specified,The provided policy document does not specify CPT/billing codes for BRCA1/2 testing; therefore a specific CPT code cannot be determined from the policy text alone.,No,"Under the BCBS FEP policy, genetic testing for BRCA1/2 in minors is considered investigational and the patient (age 12) is an unaffected minor without qualifying personal or family cancer history; therefore the test is not covered per the policy.",18927,2174,21101
Case8710,rag,all_correct,iter2,WES,Patient information explicitly states whole exome sequencing (WES) has been requested.,Yes,"Policy contains age-based references (e.g., features diagnosed by age 18). The patient is 12 years old, which meets the age-related criteria referenced in the policy (e.g., diagnoses required by age 18).",Yes,"Policy requires WES be ordered by a medical geneticist, neonatologist, neurologist, or developmental pediatrician. The test was ordered by a developmental pediatrician per the patient information.",Not Answerable,"Policy requires specific clinical features be present (either one of the primary features or two or more of the secondary features such as autism spectrum disorder plus additional listed features). The record states ASD plus “at least one additional abnormality affecting another organ system” but does not specify which additional feature(s) are present or that the results are expected to directly influence management, so it cannot be determined from the provided information whether the policy's medical-indication criteria are met.",Not Specified,"The policy does not mandate prior testing (e.g., CMA or karyotype) before postnatal WES in this context; it only specifies prior testing in certain prenatal or syndrome-specific circumstances. Patient had a nondiagnostic karyotype, but the policy does not require specific prior tests generally for WES in this scenario.",Not Answerable,"The policy lists family history (other first- or second-degree relatives with similar clinical features) as a supportive feature. The patient has a paternal uncle with dystonia/ataxia (a second-degree relative), but it is not documented that the uncle’s features are 'similar clinical features' to the patient’s phenotype, so it cannot be determined whether the family history meets the policy criterion.",Not Specified,"The policy states genetic counseling is 'strongly recommended' prior to WES/WGS but does not make counseling a stated coverage requirement. The patient record documents no pre-test counseling; however, because the policy only recommends (not requires) counseling, counseling is not a coverage precondition per policy.",81415,The policy's Applicable Codes list maps exome sequence analysis to CPT code 81415 (Exome; sequence analysis) which corresponds to WES requested.,No,"Per the UnitedHealthcare WES policy, coverage requires that all specified criteria be met (nonspecific presentation, appropriate ordering provider, and presence of required clinical features / indications with expectation that results will directly influence management). Although age and ordering provider criteria are met and prior karyotype was nondiagnostic, the documentation does not specify the additional organ-system abnormality or demonstrate that the required clinical-feature thresholds and expectation to influence management are met. Because the policy's medical-indication requirements cannot be confirmed from the provided information, the request is not covered per policy.",36953,3622,40575
Case16246,rag,all_correct,iter2,BRCA1/2,Patient is explicitly referred for BRCA1 and BRCA2 testing per the clinical information. Policy lists BRCA1/2 testing as a covered single-gene test.,Yes,"Policy: 'BRCA1/2 gene testing is proven and medically necessary for individuals with a personal history of Breast Cancer diagnosed at age 65 or younger.' Patient is 35 with breast cancer, meeting the age criterion.",Not Specified,"Policy strongly recommends pre-test genetic counseling and involvement of genetics-experienced providers for panels, but it does not mandate a specific ordering provider type for BRCA1/2 single-gene testing; no explicit ordering-provider requirement is specified.",Yes,"Policy: BRCA1/2 testing is medically necessary for individuals with a personal history of breast cancer diagnosed ≤65. Patient has personal history of breast cancer diagnosed before age 50, satisfying the medical indication.",Not Specified,"Policy does not require prior diagnostic testing (e.g., tumor testing) or prior genetic tests before BRCA1/2 single-gene testing; no specific prior-test completion requirement is specified.",Yes,"Policy defines BRCA-related cancers to include pancreatic cancer and includes criteria referencing a close blood relative with a BRCA-related cancer. Patient has an uncle (a second-degree relative) with pancreatic cancer, which is relevant per policy.",Not Specified,Policy states 'Pre-test genetic counseling is strongly recommended' but does not make counseling a required coverage condition for BRCA1/2 testing; therefore counseling requirements are not specified as mandatory.,81162,"Policy Applicable Codes: CPT 81162 corresponds to BRCA1/BRCA2 full sequence analysis plus duplication/deletion analysis, matching the requested BRCA1/2 testing.",Yes,"Patient meets coverage criteria: she has a personal history of breast cancer diagnosed at age 65 or younger (age 35). Policy states BRCA1/2 testing is proven and medically necessary in this situation, so the test is covered.",38615,1924,40539
Case14017,rag,all_correct,iter2,WES,Patient record explicitly states 'whole exome sequencing (WES) has been ordered.',Yes,"Policy applies to children/infants (standard WES 'for...children'); the patient is a 7-week-old infant, which meets the age-related applicability in the policy.",No,Policy requirement #1: 'Documentation that the individual has been evaluated by a clinician with expertise in clinical genetics...and counseled.' The record states evaluation by a general pediatrician; there is no documentation that a clinician with genetics expertise evaluated the infant.,Yes,Policy examples list 'Infant with high risk stratification on evaluation for a Brief Resolved Unexplained Event (BRUE)... Recurrent witnessed seizure like events' as a clinical feature suggesting a genetic disease; the patient has a high-risk BRUE with recurrent witnessed seizure‑like events.,No,"Policy states genetic etiology should be considered despite previous genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing). The patient had a nondiagnostic karyotype but no documentation of prior CMA or targeted single‑gene testing required by the policy.",Yes,"Policy considers relevant family history (examples include genetic disease/neurodevelopmental disorders). The patient has a family history of neurologic disease (maternal uncle with movement disorder), which is relevant per policy.",Yes,Policy requires genetic counseling ('counseled about the potential risks of genetic testing'); the record documents that pre-test genetic counseling was completed with plans for post-test follow-up.,81415,"CPT 81415 corresponds to exome sequencing (clinical WES), which matches the requested whole exome sequencing.",No,"Although age, clinical indication (high-risk BRUE with recurrent seizure‑like events), family history, and pre-test counseling are consistent with the policy, the policy's medical‑necessary standard WES requires (1) evaluation by a clinician with expertise in clinical genetics and (3) prior testing such as CMA/targeted testing be nondiagnostic or bypassed; these required elements are not documented. Per the policy (all listed criteria must be met), the test is not covered.",14857,2786,17643
Case5674,rag,all_correct,iter2,WES,Patient facts state the team plans whole exome sequencing (WES) to investigate a possible genetic epilepsy syndrome.,Yes,"Policy applies WES to children for evaluation of unexplained congenital or neurodevelopmental disorders; the patient is a 9-year-old child, so age criterion for a 'child' is met (policy: '...may be considered medically necessary ... in children...').",Yes,"Policy requirement 1: documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled. Patient has had multiple visits with a genetic counselor and arrangements for post-test genetics follow-up, satisfying the policy's evaluation/counseling requirement.",Yes,"Policy lists 'persistent seizures' as a clinical feature suggesting a genetic disease and requires prior testing be nondiagnostic or a genetic etiology be most likely; patient has persistent seizures and prior CMA was nondiagnostic, meeting the medical indication criteria.",Yes,"Policy criterion 3 requires prior genetic testing (eg, CMA) be nondiagnostic or failed to yield a diagnosis; patient had a prior CMA that was nondiagnostic, meeting the prior test requirement.",Yes,Policy guideline lists family history of sudden unexplained death in first- or second-degree relatives before age 35 as relevant; patient has an uncle with sudden unexplained death before age 35 (relevant family history).,Yes,"Policy requires counseling about risks of genetic testing by an individual with genetics expertise; patient has had multiple visits with a genetic counselor, meeting the counseling requirement.",Not Specified,The provided BCBS_FEP WES/WGS policy text does not list or specify CPT billing codes for whole exome sequencing.,Yes,"All policy-required elements are met: patient is a child with persistent seizures (a listed clinical feature), prior CMA was nondiagnostic, genetic counseling has occurred, relevant family history is present, and evaluation/arrangements with genetics exist—therefore WES may be considered medically necessary per the policy.",14831,2239,17070
Case9773,rag,all_correct,iter2,CMA,Patient info states chromosomal microarray (CMA) was ordered; policy FEP 2.04.59 addresses CMA testing for developmental delay/intellectual disability.,Yes,Policy specifies CMA as first-line testing in 'infants or children' with developmental delay/ID; the patient is a 2-year-old child and therefore meets the age/applied population in the policy.,Not Specified,The policy discusses genetic counseling and genetics evaluation but does not specify mandatory ordering-provider specialties or credentials required to order CMA for coverage.,Yes,"Policy lists 'apparent nonsyndromic developmental delay/intellectual disability' as an indication for CMA; the patient has severe intellectual disability, meeting that clinical criterion.",Not Specified,The policy treats CMA as first-line testing in the initial evaluation and does not mandate completion of specific prior tests before performing CMA (fragile X is referenced as part of first-tier approaches but not as a required prior test).,Not Specified,"The policy does not define family history or consanguinity requirements for CMA coverage; although a maternal aunt with an immunologic disorder is noted in the patient record, the policy does not make this a coverage criterion.",Not Specified,"The policy strongly recommends formal genetic counseling and describes who should provide it, but it does not state genetic counseling as an explicit coverage prerequisite; patient had pre-test counseling per record.",Not Specified,The provided policy text does not list or map specific CPT codes to CMA testing; therefore a CPT code cannot be determined from the policy document alone.,Yes,"Per FEP 2.04.59, chromosomal microarray analysis 'may be considered medically necessary as first-line testing' for individuals with developmental delay/intellectual disability; the 2-year-old with severe ID and no prior testing meets this coverage criterion.",15707,1695,17402
Case18257,rag,all_correct,iter2,BRCA1/2,Patient is being evaluated for BRCA1/2 testing to assess hereditary breast and ovarian cancer risk; request explicitly for BRCA1/2.,Yes,"Policy age requirement for BRCA full sequence analysis is ≥18 years; patient is 64, meeting age-based eligibility.",Not Specified,"The policy requires pre- and post-test genetic counseling by an appropriate provider but does not specify required ordering provider specialty; the ordering provider is a general practitioner, which the policy does not explicitly prohibit or require.",Yes,"Full sequence analysis diagnostic criteria include 'female with breast cancer diagnosis 50 years of age or younger'; patient had breast cancer diagnosed ≤50, so meets a defined medical indication.",Yes,"Policy requires no prior BRCA full sequencing/deletion-duplication; patient has had chromosomal microarray (CMA) only (nondiagnostic), with no prior BRCA testing documented.",No,Policy specifies relevant family history criteria (first-/second-/third-degree relatives with cancers); patient’s family history (a sibling with short stature) is not a qualifying cancer family history per the policy.,No,Policy requires pre- and post-test genetic counseling by an appropriate provider for BRCA testing; there is no documentation of prior genetic counseling for this patient.,81162,Policy lists CPT 81162 as the likely appropriate code when BRCA1/2 sequencing is performed concurrently with deletion/duplication analysis (full sequencing + del/dup).,No,"Although the patient meets age and medical indication and has no prior BRCA testing, the policy requires documented pre- and post-test genetic counseling for BRCA full sequence analysis and this is not documented; therefore coverage criteria are not fully met.",10263,2060,12323
Case10075,rag,all_correct,iter2,CMA,Patient info explicitly states consideration of chromosomal microarray (CMA) testing; policy document is CMA-focused for developmental delay/congenital anomalies. Basis: patient clinical note ('consideration of chromosomal microarray (CMA) testing').,Not Specified,Policy does not define explicit age-based inclusion/exclusion criteria or age limits for CMA; it addresses postnatal individuals generally. Basis: FEP 2.04.59 policy statements and guidelines do not specify age cutoffs.,Not Specified,Policy recommends genetic counseling by an experienced provider but does not specify required ordering provider specialties or explicit ordering-provider requirements for CMA coverage. Basis: 'Genetic counseling ... should be performed by an individual with experience...' without ordering-provider mandates.,No,"Policy limits medically necessary CMA to (1) apparent nonsyndromic developmental delay/ID, (2) autism spectrum disorder, or (3) multiple congenital anomalies not specific to a well-delineated syndrome. The 4-week-old has meconium ileus (a single congenital finding) and no stated developmental delay/ASD or multiple congenital anomalies; prior CMA was nondiagnostic. Basis: FEP 2.04.59 policy statement listing covered indications.",Not Specified,Policy does not require completion of specific prior tests before CMA in the documented policy language (it recommends a stepwise approach for ASD but does not mandate prior tests as a general coverage prerequisite). Basis: Policy Guidelines and Benefit Application lack explicit prior-test prerequisites for CMA.,Not Specified,"Policy does not list family history or consanguinity as a defined coverage criterion for CMA in the provided policy statements. Although the patient has a sibling with an inborn error of metabolism, the policy's coverage indications do not hinge on family history. Basis: Covered indications are developmental delay/ID, ASD, or multiple congenital anomalies.",Not Specified,"Policy strongly recommends formal genetic counseling and states it should be performed by experienced personnel, but it does not state counseling as an explicit mandatory coverage criterion. The patient did have pre-test counseling, but the policy does not require counseling as a condition for coverage. Basis: 'experts recommend formal genetic counseling...' language in policy.",Not Specified,The provided policy document does not specify or list CPT codes corresponding to CMA or other tests. Basis: no CPT code information in FEP 2.04.59 text provided.,No,"Per policy, CMA is medically necessary only for (1) nonsyndromic developmental delay/ID, (2) ASD, or (3) multiple congenital anomalies. The infant has a single congenital issue (meconium ileus) and no documented developmental delay/ASD or multiple anomalies; prior CMA was nondiagnostic and policy does not address repeat CMA. Therefore the request does not meet the policy-defined medical indication for coverage. Basis: FEP 2.04.59 policy statement of covered indications.",15704,1983,17687
